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GENERAL INTRODUCTION 
Antibodies against hormones play an important role in 
endocrinological research. This concerns primarily the use in radio-
immunoassays for the measurement of hormones in biological fluids. 
When the phenomenom of insulin resistance in insulin-treated 
diabetics was investigated, it was first demonstrated that a 
Proteohormone can at all induce the formation of an antibody. The 
availibility of hormone antibodies has led to the introduction 
of the radioimmunological technique, as described by Yalow and 
Berson (1960) for the determination of plasma insulin in man. 
Initially, the radioimmunoassay could only be applied to protein 
and polypeptide hormones which, due to their high molecular weight 
are immunogenic per se. Hormones of low molecular weight like 
steroids become immunogenic only when covalently coupled to a 
carrier protein. Steroid antibodies were available since 1957, when 
Erlanger et al. first succesfully produced antibodies against 
steroid hormones. However, these antibodies had relatively low 
affinities and therefore could not be of much use m radioimmuno-
assay. The first application of steroid antibodies m radio-
immunoassay was published in 1969 by Abraham et al. for the 
measurement of plasma estradiol-17ß. Whereas most investigators 
immunized experimental animals to produce steroid antibodies for 
radioimmunoassay purposes, a small group of workers studied the 
possibility of using antibodies for immunological neutralization of 
hormonal activity. Since neutralization of biologically active 
molecules by binding to specific antibodies is a basic principle 
of immunology. Two approaches were used; either the antibodies 
were administered directly to the animal (passive immunization), 
or the animal was made to produce its own antibodies after immuniza-
tion with the immunogen (active immunization). One of the original 
goals of Erlanger et al. (1975) was the use of steroid antibodies 
to inhibit the biological activity of circulating steroid hormones. 
They showed for instance, that the effects of estrone, testosterone, 
Cortisol or aldosterone could be abolished by the administration of 
the respective antibodies to test animals (Lieberman et al., 1959; 
Neir et al., 1964). Efforts were made to determine whether a similar 
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neutralization of the biological activity of steroid hormones can 
be obtained by active immunization. In studies, in which animals 
were actively immunized with steroid-protein conjugates, effects 
were observed which might indicate that the amount of biologically 
active hormone in these animals was decreased (Nieschlag et al., 
1973; Sundaram et al., 1973; Nieschlag et al., 1974). As it is 
assumed that only the free, non-protein bound, fraction of a steroid 
hormone is biologically active, it was suggested that a decrease 
in biological activity was caused by a reduction in free hormone 
levels. However, since there was no reliable and sensitive method 
available to determine the free hormone concentration, in none of 
these studies the observed biological effects could be related to 
changes in free hormone levels. Methods described for the deter-
mination of the concentration free steroid hormone in plasma are 
generally based on equilibrium dialysis which is considered to be 
the most reliable technique as pointed out by Westphal (1971) and 
Kurz et al. (1977) . However, this method relies on the purity of 
the radiolabelled hormone used to determine the free hormone 
fraction, which constitutes a major source of error at high binding 
levels. As described by Nieschlag et al. (1974), Hillier et al. 
(1975) and Haack et al. (1979), who applied this method on plasmas 
of animals actively immunized against steroid-protein conjugates, 
it appeared that the equilibrium dialysis technique was not suffi-
ciently sensitive for detecting small changes in binding at levels 
greater than 99%. Nor was the method precise enough to allow calcu-
lation of the free concentration. Criticism concerning the applica-
bility of this equilibrium dialysis technique for the dtermination 
of the free hormone concentration in actively immunized animals has 
also been stated by Nieschlag et al. (1975), Thorneycroft et al. 
(1975) and Wickings and Nieschlag (1978). It has been concluded 
that all studies involving active immunization against steroids 
seems to lack a sensitive and reliable method for the determination 
of the free hormone fraction, so that an accurate assesment of the 
free concentration has not been achieved to date. 
The purpose of this thesis was to investigate whether - or 
to what extent - active immunization against a steroid hormone 
leads to neutralization of hormonal activity and to obtain insight 
into the mechanism by which neutralization takes place. The model 
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chosen for investigation was active immunization of intact sheep 
with an aldosterone-protein conjugate. The effect of immunization 
on circulating aldosterone was studied by measuring the total and 
the free, non-protein bound, plasma aldosterone concentrations. 
Since the plasma electrolyte level in man and in animals is depen-
dent on the plasma concentration of aldosterone (August et al., 
1958; Ross, 1963; Knöchel and White, 1973; Young et al., 1977) 
plasma sodium and potassium levels were determined as an indicator 
of aldosterone hormonal activity. 
In Chapter 1, the production of an antiserum to aldosterone by 
immunization of sheep with aldosterone 21-monohemisuccinate-BSA 
is described and its application in a radioimmunoassay for the 
determination of total aldosterone in plasma. The method described 
is evaluated in detail according to criteria of specificity and 
reliability. Despite excellent specificity of the used antiserum, 
the relative amounts in which other plasma steroids occur necessi-
tate an initial extraction and purification procedure prior to the 
immunoassay. 
In Chapter 2 a method for the determination of the free aldoste-
rone concentration in sheep plasma is described which is independent 
of the binding levels of the hormone. This method implies equili-
brium dialysis of a plasma sample against phosphate buffer followed 
by radioimmunoassay of aldosterone in the buffer solution. The 
specificity and reliability of this combined equilibrium dialysis 
and radioimmunoprocedure is tested. The concentration of free 
aldosterone in plasma is calculated from the concentration of 
aldosterone in the buffer solution by a formula which takes into 
account the changes in the volume of plasma and buffer during 
dialysis. The radioimmunoprocedure used to measure aldosterone in 
the buffer solution is a modification of the radioimmunoassay 
developed for the determination of total aldosterone directly in 
human plasma, i.e. without extraction and purification. In this 
assay a highly specific antiserum is used which is obtained by 
immunizing sheep, with aldosterone-(18, 21)-diacetate-3-carboxy-
methyloxime-BSA. The direct radioimmunoassay of total aldosterone 
in human plasma and the production of this antiserum are also 
described in this Chapter. 
To study the effect of active immunization against aldosterone 
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on the free plasma concentration of this steroid hormone, nine 
sheep were immunized with aldosterone-21-monohemisuccinate-BSA 
(Chapter 3). The anifnals were studied for a period more than a 
year together with nine sham-immunized sheep as controls. The effect 
of immunization on the free aldosterone levels was determined by 
measuring the concentration in plasma collected at various times 
after primary immunization. Also total aldosterone concentration, 
antibody titre and the free aldosterone fraction in these plasmas 
were measured. Total and free plasma aldosterone levels were 
determined using the methods described in Chapter 1 and 2, respec-
tively. Furthermore, to identify the cause of the marked increase 
in total plasma aldosterone in animals actively immunized with an 
aldosterone-protein conjugate (Gless et al., 1974; Nieschlag et al., 
1974; Haack et al., 1979) immunization with radiolabelled aldosterone 
21-monohemisuccinate-BSA and metabolic clearance determinations of 
aldosterone in control and immunized sheep have been included in 
this Chapter. 
In Chapter 4, plasma sodium and potassium concentrations in 
control sheep and in sheep actively immunized against aldosterone are 
presented. The electrolyte concentrations are considered in view 
of the free aldosterone levels described in Chapter 3 to investigate 
how free aldosterone and electrolyte levels are related and in 
what manner these relations are affected by immunization . Some 
further experiments are described in this Chapter to explain the 
observed effects on electrolyte levels in terms of a modified 
relation between the secretion and the free plasma concentration of 
aldosterone . 
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Chapter 1 
RADIOIMMUNOASSAY OF ALDOSTERONE IN PLASMA 
INTRODUCTION 
For the assay of aldosterone in plasma highly specific analytical 
methods are essential since its concentration is extremely low 
relative to other, structurally similar corticosteroids. Cortisol, 
for example, is present in plasma at about a thousand times the 
concentration of aldosterone. Double isotope derivative assay 
techniques have been developed (Kliman and Peterson, 1960; Benraad 
and Kloppenborg, 1965; Brodle et al., 1967; Coghlan and Scoggins, 
1967; Nowaczynski et al., 1967) which approach the required 
sensitivity and specificity for measuring these low concentrations. 
However, these methods involve a time consuming and complex set of 
procedures which permit the determination of relatively few samples. 
For instance, the classical method of Kliman and Peterson (I960) 
employs two radioisotopes, an acetylation and three paper chromato-
graphy steps. This criticism is also applicable to gas-liquid 
chromatography (Fabre et al., 1969; Nicolis and Gabrilove, 1969; 
Siekmann et al., 1972) which seemed to rival the techniques mentioned 
before. 
The application of the radioimmunological technique, as described 
by Yalow and Berson (1960) for the determination of plasma insulin 
in man, offers an attractive alternate method. In principle this 
technique is based on the competition between labelled and unlabelled 
hormone for the binding sites on the antibody. The hormone concentra-
tion of an unknown sample is determined from the percentage 
radioactivity bound to the antiserum by reference to a standard curve. 
Initially, the radioimmunoassay could only be applied to protein and 
polypeptide hormones which, due to their high molecular weight are 
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both antigenic as immunogenic. An antigen is defined as a substance 
which can be bound by a specific antibody while an immunogen is a 
substance which induces the formation of antibodies. Substances like 
steroids, with a low molecular weight, can be bound as antigens by 
antibodies though they are not capable to elicit the production of 
these antibodies. However, many steroids can be rendered iirœrunogenic 
by coupling their 3-oxime or 21-hemisuccinate derivatives to bovine 
serum albumin (Erlanger et al., 1957). In this way antibodies to 
aldosterone have been raised by Neri et al. (1964). The first 
publications on antisera utilization in radioimmunoassay techniques 
for the measurement of plasma aldosterone were from Bayard et al. 
(1970) and Mayes et al. (1970). These methods have the advantage 
that they are sensitive, specific and that they can be carried out 
rapidly. 
In this study, the production of a useful antiserum to aldosterone 
21-monohemisuccinate-BSA and its application in a radioimmunoassav 
for the determination of aldosterone in plasma is reported. The method 
described is evaluated in detail according the criteria of speci-
ficity and reliability. 
MATERIALS AND METHODS 
Reagents 
D- [l,2- H] Aldosterone, 50 Ci/mmol, obtained from New England 
Nuclear, was dissolved in ethanol and rechecked for purity at 
regular intervals by paper chromatography in the Bush B- system. 
The hormone solution was stored at -20 C. 
Unlabelled d-aldosterone(Steraloids)was used without purification. 
A solution of the steroid in ethanol was stored at -20 C. 
Benzene, dichloromethane and methanol, all "instra-analyzed quality" 
were obtained from Baker; ethylene glycol and ethanol from Merck. 
These solvents were used without further purification. 
Aldosterone 21-monohemisuccinate-BSA (Steraloids) together with 
Freund's complete adjuvant (Calbiochem-Behring Corp.) was used 
for immunization. Instagel (Packard) served as counting solution 
for radioactivity measurements. Other reagents and their sources 
were dextran T70 (Pharmacia), Norite A (Fisher) human γ-globulin 
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(Behring Werke). 
The γ-globulin buffer solution used in the radioimmunoassay was a 
0.05 M borate buffer (pH 8.0) containing 0.1% human γ-globulin. 
Dextran-coated charcoal was prepared by adding 1 volume charcoal 
suspension (5 g Norite A in 80 ml γ-globulin buffer) to 3 volumes 
dextran solution (100 mg dextran in 80 ml γ-globulin buffer). The 
mixture was stirred 10 min prior to use. 
Materials 
Blood samples were collected in 10 ml polystyrene tubes 
(16x100 mm) with round bottom (Thovadex Hospidex, Nieuwkoop). For 
chromatography a Shandon Chromatank model 300 with Whatman No.l 
paper was used. Paper strips were scanned for radioactivity on a 
TMC Model 880 Autoscanner. Two ml polypropylene Brunswick syringes 
(Sherwood) were used for the elution of aldosterone after chroma­
tography. Polystyrene test tubes (10.5x40 mm) with caps (Greiner, 
Nürtingen, G.F.R.) were employed for the radioimmunologic reaction. 
Radioactivity measurements were performed in a Searle Isocap 300 
liquid scintillation counter using polyethylene counting vials 
(New England Nuclear). Results were calculated on a programmable 
Wang 600 desk top calculator. 
Immunization procedure and characterization of antisera 
Three sheep were immunized with aldosterone 21-monohemisuccinate-
BSA carrying 15-20 moles steroid per mole BSA. Approximately 1.5 mg 
of the conjugate, dissolved in 1 ml 0.9% saline and emulsified in 
an equal volume of Freund's complete adjuvant, was used for the 
initial injection. The suspension was injected subcutaneously at two 
sites in the back. Boosters of 1 mg of the conjugate emulsified in 
the same adjuvant were given at varving intervals during a period of 
four months. The sheen were bled from the jugular vein and blood was 
collected in polystyrene tubes. The blood was allowed to clot for 
2h and the serum, obtained after 20 min centrifugation at 3000 rpm 
at room temperature, was then frozen in polystyrene tubes in 1 ml 
portions and stored at -20oC. Stock solutions of some antisera were 
prepared in a dilution of 1:100 in the γ-globulin buffer and stored 
in 1 ml portions at -20 C. 
The anti-aldosterone sera thus obtained, were characterized by 
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testing their titre, specificity and affinity. The titres were 
determined by preparing an antibody dilution curve. Serial dilutions 
of each serum, in the γ-globulin buffer, were incubated with 7500 dpm 
Η-aldosterone according the procedure described under immunoassay. 
The reaction volume consisted of 300 yl ethylene glycol/water 0.2%, 
100 yl Η-aldosterone and 200 μΐ of the antiserum dilution. The 
percentage radioactivity bound to the antiserum was plotted against 
increasing dilutions of the antiserum. The titre of the antiserum 
was defined as the reciprocal of the dilution factor at which 50% 
of the added Η-aldosterone was bound. This dilution was used in 
the standard curve for the study of the specificity. The speoificity 
is tested by setting up standard curves with the steroids listed in 
Table 1.1. Serial dilutions were made of each steroid in ethylene 
glycol/water 0.2% and to 300 yl of this solution, 100 yl H-aldo-
sterone and 200 yl antiserum, in the appropriate dilution, were 
added. The percentage radioactivity bound was determined, as described 
under Immunoassay, and plotted against the amount of steroid in the 
test tube. The percentage cross reaction, with respect to aldo­
sterone, is calculated at the 50% level according to Abraham (1969). 
If χ pg aldosterone are required to give a displacement of 50% of 
the bound radioactivity and y equals the pg of the tested steroid 
which displaces the same amount of radioactivity, then the percen­
tage cross reaction of this steroid is x/y χ 100. The affinity 
constants for the antisera obtained, were determined by plotting the 
standard curve of aldosterone as a Scatchard plot (1949). The affinity 
constant was calculated from the slope of the line obtained. 
Plasma extraction and chromatography 
The flow sheet of the procedure for the isolation of aldosterone 
from plasma is shown in Fig. 1.1. Twenty-three samples of 2 ml 
plasma could be conveniently processed together with an equal 
volume of a pooled plasma sample. In order to calculate recovery 
and to locate aldosterone on the paper chromatogram, 7500 dpm of 
Η-aldosterone in 100 yl of ethylene glycol/water 0.2% was added. 
After incubation for 30 min at room temperature, 15 ml dichloro-
methane was added to the samples and the mixture was shaken for 
2 min. The dichloromethane layer was seperated from the plasma 
layer by centrifugation for 2 min at 1000 rpm in a table centri-
18 
1. 2 ml plasma + 100 ul H-aldosterone (7500 dpm) 
2. Incubation for 30 min. at room temperature 
3. Extraction with 15 ml dichloromethane 
4. Aspiration of aqueous layer and evaporation of 
dichloromethane to dryness 
5. Paper chromatography in Bush Be system 
6. Detection of aldosterone by paper scanning 
7. Elution with 1 ml ethylene glycol/water (0.2%) 
Fig. 1.1. Flow sheet of the extraction and chromatographic puri­
fication of aldosterone from plasma. 
fuge. The plasma layer was removed by aspiration and the organic 
layer was evaporated to dryness in a water bath at 40 С under a 
stream of air. The residue was dissolved in dichloromethane and 
applied under an air stream on paperstrips, 3 cm wide and 50 cm 
long. Chromatography was performed for 4h at room temperature 
in the Bush Bj- system (benzene/methanol/wateiTf 10:5:5). The sta­
tionary phase was stored in the chromatography tank; the mobile 
phase was added Ih after incubation of the strips in the tank. 
After chromatography the strips were dried and scanned for radio­
activity. They were then cut 2 cm above and 2 cm below the maximum 
of the radioactivity peak. The paper strips were eluted with 1 ml 
ethylene glycol/water 0.2% in 2 ml syringe. Duplicate aliquots 
of 300 yl of the eluate were taken for radioimmunoassay and an 
aliquot of 150 μΐ was assayed for radioactivity to determine recovery. 
Immunoassay 
For the immunoassay duplicate aliquots of 300 μΐ of the chroma-
togram eluate of each sample were transferred to test tubes. For the 
standard curve concentrations of 0, 5, 10, 20, 40, 80, 160 and 320 pg 
of aldosterone were used in duplicate. The standards were chosen 
in such a way that the amounts were doubled at each consecutive 
point on the curve when a log scale was used. The standard solutions 
in ethanol were diluted with ethylene glycol/water 0.2% to give the 
final concentration per 300 ul. For determination of the blank value 
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300 μΐ of a paper eluate was pipetted into two test tubes. The paper 
eluate was obtained by eluting a 4 cm piece cut from a non-chroma-
tographed paperstrip. Two tubes were filled with 100 μΐ of the 
recovery tracer; the volumes were made up to 300 μΐ with ethylene 
glycol/water 0.2%. These tubes were subsequently used to correct the 
plasma samples for the pg aldosterone arising from the recovery 
tracer. 
To all test tubes was added 100 μΐ 3H-aldosterone (7500 dpm) and 
200 μΐ of a 1:250.000 diluted antiserum solution. Tracer and anti­
serum were dissolved in the γ-globulin buffer. The tubes were mixed 
thoroughly and incubated for 15 min at room temperature and for I8h 
at 40C. 
% bound 
5 0 • 
4 0 
3 0 
2 0 
10 
logi t (в/во) 
— ι 1— 
4 0 Θ0 320 
aldosterone (pg) 
Fig. 1.2 Standard curve for the radioimmunoassay of aldosterone ; 
22 pg of Η-aldosterone per 0.6 ml reaction volume, antiserum 
dilution 1:250.000 (left). Logit-log transformation of the stan­
dard curve where logit (B/B ) equalled In (B/B )/(l-B/B ); В is 
the percentage Η-aldosterone bound in the presence of unlabelled 
aldosterone, В is the percentage bound in the absence of unlabelled 
aldosterone (right). 
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The antibody-bound and free fraction were separated according to the 
method of Poulsen (1969). One hundredfifty microliters of the 
dextran-coated charcoal suspension is brought into disposable caps, 
which are placed on the test tubes. The suspension is mixed 
with the content of the tubes by shaking all tubes simultaneously. 
After 3 min at 4 С the tubes were centrifugea at 10.000 g for 10 min. 
The supernatants were decanted simultaneously into counting vials 
using the equipment described by Vecsei (1974) and radioactivity 
was determined. 
Calculation 
The percentage of bound radioactivity of standards and blanks was 
calculated from the counts in the supernatant and the initial number 
of counts added to the test tubes. The standard curve was construc­
ted by plotting the percentage of bound steroid against the amount 
of unlabelled aldosterone added (Fig. 1.2). For the calculation 
of the percentage bound radioactivity of plasma samples and samples 
for the determination of the aldosterone content of the recovery 
tracer, the initial number of counts added were corrected for the 
amount of counts present in the aliquot for the assay arising from 
the recovery tracer. The amount of aldosterone in the aliquots of 
plasma samples, paper eluate and recovery tracer could be directly 
determined from the above standard curve. The plasma aldosterone 
concentration in ng/100 ml was calculated from the formula: 
(Unknown - Blank - Recovery tracer) χ 100 
Recovery χ Assay aliquot χ Plasma volume 
Where: 
Unknown = amount of aldosterone (pg) read off the standard curve 
for the aliquot of an unknown sample taken in the assay 
Blank = amount of aldosterone (pg) in the aliquot of the blank 
Recovery tracer = amount of aldosterone (pg) in the aliquot arising 
from the recovery tracer; value is obtained from the specific 
activity of the recovery tracer (pg/cpm) and the radioactivity 
(cpm) present in the aliquot 
3 
Recovery = percentage of Η-aldosterone, added to the plasma, 
recovered through the extraction and purification procedure 
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Assay aliquot = volume of the paper eluate (ml) taken for assay 
Plasma volume = amount of plasma (ml) used for the extraction and 
chromatography. 
The standard curve can be linearized by utilizing a logit and 
logarithmic transformation to the dose response variables according 
to Rodbard et al. (1969). The "logit-log" transformation of a typical 
standard curve is shown in Fig. 1.2. This linearized standard 
curve made it possible to design a linear regression program. From 
this program were obtained the percentage of bound radioactivity 
of standard, samples, blank and tracer determination, the plot of 
the standard curve, the mass of aldosterone in each sample and the 
percentage recovery Η-aldosterone. The concentrations of aldoste­
rone were directly computed by the program, according to the for­
mula described above. 
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Fig. 1.3 Titres of the antisera 
raised in sheep 83 ( ), 69 
( ) and 7Θ ( ) against 
aldosterone 21-raonohemisuccinate-
BSA. 
5 10 15 20 
weeks after primary immunization 
RESULTS 
Production of antisera 
Aldosterone antibodies were succesfully raised in all three sheep 
as shown in Fig. 1.3. The highest titres were obtained 20 weeks after 
primary immunization. For sheep 83, 69 and 78 titres were 750,000, 
450,000 and 160,000, respectively. Comparing these three different 
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antisera, the antiserum with the highest titre was found to have 
also the greatest specificity for aldosterone. In Table 1.1 the cross 
reactivity of this antiserum with a number of related compounds is 
shown. Sheep 83 antiserum was used in all subsequent assays at a 
final dilution of 1 : 750,000. By replotting a standard curve 
according to the method of Scatchard (1949) the average affinity 
constant calculated for this specific antiserum was 5.4 χ IO10 
litres/mol. 
Recovery 
The mean recovery of Η-aldosterone following the extraction and 
purification procedures was 67.6 + 4.9 (SD)% (n=26). As a rule 
samples with recoveries below 40% were discarded. 
Table 1.1 Cross reactivity of antiserum S83 
Steroid Percentage of 
c r o s s ] 
100 
1 1 6 
2 0 . 
0, 
2 7 . 
< 0, 
< 0 
0, 
< 0, 
0. 
1, 
0 . 
1. 
< 0 . 
0 . 
< 0 . 
< 0 . 
r e a c t i o n 
. 0 
. 3 7 
. 6 
. 0 0 4 
. 0 0 4 
. 0 0 7 
. 0 0 4 
. 8 0 
. 1 9 
. 0 8 
. 7 6 
. 0 0 4 
. 0 9 2 
. 0 0 4 
, 0 0 4 
Aldosterone 
Aldosterone 2l-monoacetate 
Aldosterone 18, 21-diacetate 
17-Iso-aldosterone 
Aldosterone-γ-lactone 
Cortisone 
Cortisol 
11-Deoxycortisol 
21-Deoxycortisol 
Corticosterone 
11-Deoxycorticosterone 
Testosterone 
Progesterone 
9cc-Fluorocortisol 
Aldadiene 
Potass ium c a n r e n o a t e 
S p i r o n o l a c t o n e 
a l l steroids were obtained from Steraloids. 
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Specificity 
The specificity of the method relies on the combination of high 
resolution paper chromatography and the specificity of the anti­
serum. The latter was determined by measuring the percentage cross 
reaction with other steroids (Table 1.1). Despite excellent speci­
ficity, it was apparent that aldosterone had to be separated from 
other plasma steroids because of the relatively high amounts in 
which they occur physiologically. 
The suitability of the Bush B5 paper chromatography system was 
studied by examining the separation of aldosterone from other corti­
costeroids as well as other groups of hormonal steroids (Table 1.2). 
Table 1.2 R -and R -values of various steroids 
after paper chromatography in the Bush В system. 
Steroid RF RAld 
18-Hydroxycorticosterone 
l-Dehydrocortisol 
Cortisol 
Aldosterone 
Cortisone 
18-Hydroxydeoxycorticosterone 
Corticosterone 
11-DeoxyCortisol 
Aldosterone 21-monoacetate 
11-dehydrocorticosterone 
1-Dehydrotestosterone 
Testosterone 
Epitestosterone 
17a-Hydroxyprogesterone 
Progesterone 
Androstanedione 
Dehydroepiandrosterone 
Ádrenosterone 
Androstenedione 
all steroids were obtained from Steraloids. 
0 . 1 0 
0 . 1 5 
0 . 2 3 
0 . 3 4 
0 . 4 4 
0 . 6 6 
0 .76 
0 . 7 7 
0 . 8 4 
0 . 8 8 
0 . 9 1 
0 . 9 3 
0 . 9 3 
0 . 9 3 
0 . 9 5 
0 . 9 5 
0 .96 
0 . 9 6 
1.00 
0 . 2 9 
0 . 4 4 
0 . 6 8 
1.00 
1.29 
1.94 
2 . 2 4 
2 . 2 6 
2 . 4 7 
2 . 5 9 
2 . 6 8 
2 . 7 4 
2 . 7 4 
2 . 7 4 
2 . 7 9 
2 . 7 9 
2 . 8 2 
2 . 8 2 
2 . 9 4 
Of the steroids tested Cortisol (R = 0.23; R A l d = 0.68) and corti­
sone (RF = 0.44; R A l d 1.29) had mobilities that were closest to 
that of aldosterone ( τ> = 0.34; R A l d = 1.00). The quality of the 
separation of aldosterone from Cortisol and cortisone was deter­
mined using labelled steroids. Radiochromatographic analysis of a 
mixture of the^e three steroids indicated that, under the conditions 
used, an adequate separation was obtained (Fig. 1.4). Only 6.2% of 
the labelled Cortisol and 3.4% of the labelled cortisone contamined 
the aldosterone area of the chromatogram normally taken for elution. 
radioactivity (cpm) • 
5000 • 
4000 
3000 
2 000 
1000 
( aldosterone 
\_ «cortisone 
/ ·, 
·-·-. 
τ ' г 
15 20 25 30 
distance from origin (cm) 
Fig. 1.4 Separation of labelled 
aldosterone from labelled Cortisol 
and cortisone by paper chromato­
graphy in the Bush В system. After 
chromatography the paperstrip was 
cut into 1 cm pieces which were, 
after elution, assayed for radio­
activity. 
70 η 
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50 -
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3 0 -
2 0 -
1 0 -
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/ 
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Fig. 1.5 Correlation of plasma 
aldosterone values obtained by 
radioimmunoassay after paper chro­
matography with those measured af­
ter thin-layer and paper chromato­
graphy . 
10 20 30 40 50 60 70 
after thmlayer and paperchromatograpny ( ng/100ml) 
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Further evidence for specificity is shown by the similar results 
obtained, analyzing plasma samples using the routine method described 
above and an additional thin-layer chromatography before the paper 
chromatography of the routine method (Fig. 1.5). 
Parallelism 
The parallelism of the method was determined by assaying various 
volumes of the same paper eluate obtained from different plasmas. 
The results of measuring aldosterone in 100-, 200- and 300 yl 
aliquots of the eluate are shown in Fig. 1.6. A linear relation­
ship was observed up to a value of 200 pg on the standard curve. 
aldosterone ( pg ) . . 
Blank and sensitivity 
It was established that the blank of the method is essentially the 
result of elution from the chromatography paper. For the determina­
tion of the blank value, the eluate of a 4 χ 3 cm area of a non-chro-
matographed paperstrip was used. In the routine measurement of 
plasma aldosterone duplicate aliquots of 300 yl of such a paper eluate 
were always included in every assay. The mean blank value found in 
44 assays was equivalent to 4.1 + 2.1 (SD) pg aldosterone. 
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The sensitivity of the immunoassay can be expressed as the error 
of estimation, which is defined as twice the standard deviation, of 
the blank value within one assay. The standard deviation was + 1.2 pg, 
therefore the sensitivity could be expressed as 2.4 pg. Regarding this 
value as the limiting factor the overall sensitivity of the method 
(S), in ng/100 ml, can be calculated according to the formula: 
S . 2S- χ ψ χ ìtx ψ 
Where: SD = standard deviation of blank value (ng) 
R = recovery of the sample (%) 
Ц. = fraction of the eluate taken for assay 
V = volume of plasma sample (ml) 
For a 2 ml plasma sample, with a mean recovery of 67.6% and taking 
0.3 of the eluate for assay, the sensitivity appeared to be 0.6 ng/ 
100 ml. 
aldosterone measured (ng/100ml) 
40 
30 
20-
10 Fig. 1.7 Correlation between 
aldosterone measured and al­
dosterone added to steroid-
free plasma. Values represent 
means + SD of 10 determinations. 
20 30 40 
aldosterone added (ng/100ml) 
Accuracy 
Accuracy was assessed by adding different amounts of aldosterone 
standard to 2 ml aliquots of a steroid-free plasma pool. The samples 
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were analyzed and the aldosterone concentration obtained was plotted 
as a function of the amounts added (Fig. 1.7). The slope of the re-
gression line was close to one, indicating that there is no syste-
matic error in the method. The steroid-free plasma without added 
aldosterone gave a value of 0.06 + 0.45 (SD) ng/100 ml (n=12) which 
is not significantly different from zero. 
Precision 
The p r e c i s i o n of the method was e s t i m a t e d by de te rmin ing the i n t r a -
and i n t e r - a s s a y c o e f f i c i e n t s of v a r i a t i o n (CV) on plasma oools wi th 
d i f f e r e n t c o n c e n t r a t i o n s of a l d o s t e r o n e . The r e s u l t s a re p r e sen t ed 
in Table 1 .3 . 
Table 1.3 Precision of the method; mean aldosterone concentrat ion, 
standard deviat ion (SD) and coeff ic ient of va r i a t ion (CV) determined 
in five d i f fe ren t plasma pools in the same assay ( intra-assay) and 
in d i f fe ren t assays ( i n t e r - a s s a y ) . 
Pool 
plasma 
Mean 
(ng/100 ml) 
+ SD 
(ng/100 ml) 
CV 
(%) 
I n t r a - a s s a y 
I n t e r - a s s a y 
12.6 
16.5 
20.3 
42.2 
46.2 
11.4 
17.6 
26.6 
37.6 
45.9 
0.6 
0.8 
0.9 
1.6 
1.8 
1.4 
2.1 
3.0 
2.7 
5.3 
4.8 
4.8 
4.4 
3.8 
3.9 
12.3 
11.9 
11.3 
7.2 
11.5 
12 
12 
12 
12 
12 
19 
14 
16 
16 
17 
Normal value 
For the determination of the normal value , human plasma samples 
of 20 healthy subjects on unrestricted diets were analyzed. Blood 
collection was made in the upright position. The mean plasma aldo-
28 
sterone concentration found was 12.5 + 6.1 (SD) ng/100 ml; the 
individual concentrations ranged from 3.0 to 24.9 ng/100 ml. 
DISCUSSION 
The described method for the determination of aldosterone in 
plasma has been shown to be specific, sensitive, accurate and repro-
ducible. The purification of aldosterone by only one paperchromato-
graphic step and the subsequent immunoassay makes this method rapid 
and simple when compared to the double isotope dilution technique 
and gas-liquid chromatography. 
In the determination of plasma aldosterone, specificity is 
exceptionally important since, compared with other steroids, the 
concentration of aldosterone is small. The plasma levels of Cortisol 
and corticosterone, for example, are 1000 and 100 times higher than 
of aldosterone, respectively. Although a specific antiserum is 
obtained with a high antibody titre and a low cross reactivity for 
other steroids than aldosterone, the relatively high concentration 
of interfering steroids made nurification necessary. After chromato-
graphy in the Bush B5 system 6.2% of the Cortisol and 3.4% of the 
cortisone contaminated the aldosterone area of the oaperstrin taken 
for elution (Fig. 1.4). Taking into consideration the cross reactivi-
ty of these steroids with the antiserum, which is less than 0.004%, 
the influence of the contamination on the aldosterone value would 
be negligible. This was confirmed by the experiment which compares 
the results of the routine method with those obtained using additio-
nal thin-layer chromatography before the paper chromatography of the 
routine method (Fig. 1.5). The values obtained by both methods were 
similar, which indicate that cross reacting substances do not inter-
fere significantly in the immunoassay. Evidence against non-specific 
interference was also provided by the parallelism of the method, 
where immunoassayable aldosterone was found to be proportional to 
the volume of the paper eluate (Fig. 1.6). Non-specific competing 
ligands, as for instance Cortisol and cortisone, might be expected 
to interfere in a non-linear fashion with the volume of the eluate. 
A factor which contributes to the specificity of the method is 
its low blank. The use of "instra-analyzed quality" solvents for 
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extraction and chromatography, which produce blank values below the 
limit of detection, reduces the blank to materials originating from 
the Whatman filter paper employed for chromatography. Washing the 
chromatography paper did not eliminate the blank value arising from 
this source. When plain Whatman No. 1 paper was used in 44 assays 
the mean blank value was 4.1 + 2.1 (SD) pg. This value is higher 
than that reported by Mayes et al. (1970) and Underwood and Williams 
(1972) i.e., 0 + 2 (SD) pg and 2 + 2 (SD) pg, respectively; but is 
lower than that of Corvol et al. (1973) i.e., 26 + 14 (SD) pg, and 
even more than 20-fold less than that of Bayard et al. (1970). 
In the radioimmunological step of the assay, part of the labelled 
and unlabelled aldosterone present in the test tubes is derived from 
the recovery tracer. As noted in the section on Materials and Methods, 
7500 dpm of Η-aldosterone was added to the plasma samples for 
correction of the losses occuring during extraction and purification 
of aldosterone. Since the average recovery was 67.6% and since 0.3 
ml of the final eluate was used for the assay, the amount of 3H-
aldosterone in the aliquot for assay was 1521 dpm. Because 7500 dpm 
of Зн-aldosterone was added for the immunoassay, in the calculation 
of the percentage bound radioactivity a correction was made for the 
radioactivity arising from the recovery tracer. Since 1521 dpm equals 
4.5 pg aldosterone, as determined from the specific activity of the 
recovery tracer, the amount of aldosterone read off the standard 
curve was also corrected. 
With the present method, the mean value obtained for normal human 
plasma was in good agreement with those published by various groups 
of investigators using similar or different radioimmunological 
methods (Table 1.4). 
In conclusion, this practical method can be used both for clinical 
assays and demanding research purposes, because it is highly specific 
and fulfils the criteria for reliability. 
SUMMARY 
An accurate and relatively simple radioimmunoassay for the 
measurement of aldosterone in human plasma is described. The assay 
uses an antiserum raised in sheep against aldosterone 21-monohemi-
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Table 1.4 Normal plasma aldosterone values (ng/100 ml) 
measured by radioimmunoassay as reported by other in­
vestigator. Plasma samples were obtained from healthy 
subjects with no dietary restriction, in the upright 
position. 
Investigator Mean + SD Purification method 
Bayard et al. (1970) 
Corvol et al. (1973) 
Farmer et al. (1973) 
Klumpp et al. (1974) 
Mayes et al. (1970) 
McCaa et al. (1972) 
Pakarmen et al. (1976) 
StCyr et al. (1972) 
Varsano-Aharon and 
Ulick (1973) 
This report 
12.2 + 7.4 (n=7) Paper chromatography 
17.2 + 7.8 (n=10) Paper chromatography 
14.9 + 6.3 (n=5) Liquid-liquid partition 
15.4 + 5.7 (n=35) Paper chromatography 
13.2 + 8.9 (n=8) Column and paper-
chromatography 
22.9 + 2.2 (n=6) Paper chromatography 
11.2 + 7.8 (n=31) Column-chromatography 
15.5+6.6 (n=16) Thin-layer chromatography 
11.2 + 1.9 (n=6) Liquid-liquid partition 
12.5 + 6.1 (n=20) Paper chromatography 
succinate coupled to bovine serum albumin. Two ml of plasma, with 
Η-aldosterone as internal standard, was extracted with dichloro-
methane and purification achieved by paper chromatography in the 
Bush B 5 system. Samples and standards are incubated for 18h at 
40C with Η-aldosterone and dilute antiserum. Bound and free aldos­
terone were separated using dextran-coated charcoal. The mean 
recovery of Η-aldosterone, after extraction and chromatography, 
was 67.6 + 4.9 (SD)%. The specificity of the method was confirmed 
by comparing the results obtained with those after extension of the 
purification. Parallelism studies yield a linear relationship 
between the amount of aldosterone measured and the volume of the 
paper eluate. The method had a non-specific blank value of 4.1 + 
2.1 (SD)pg, when 30% of the paper eluate was used, and the sensiti­
vity was 0.6 ng/100 ml. A correlation coefficient of 0.99 between 
the amount of aldosterone measured and the amount added to steroid-
free plasma confirmed accuracy. Coefficients of variation of 12.3, 
11.9, 11.3, 7.2 and 11.5% for inter-assay and of 4.8, 4.8, 4.4, 
3.8 and 3.9% for intra-assay were obtained at levels of 12.6, 16.5, 
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20.3, 42.2 and 46.2 ng aldosterone/100 ml plasma. The mean plasma 
concentration of aldosterone in normal individuals was found to 
be 12.5 + 6.1 (SD) ng/100 ml. 
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Chapter 2 
RADIOIMMUNOLOGICAL DETERMINATION OF FREE 
ALDOSTERONE IN SHEEP PLASMA DIALYSATES 
AFTER EQUILIBRIUM DIALYSIS 
INTRODUCTION 
Animals actively immunized against steroid-protein conjugates 
develop circulating antibodies which bind the corresponding steroid 
for almost 100% (Nieschlag et al., 1973; Nieschlag et al., 1974; 
Hillier et al., 1975; Wickings and Nieschlag, 1978; Martensz et al., 
1979). Since only the free, non-protein bound, fraction of a steroid 
hormone is assumed to be biologically active (Slaunwhite and 
Sandberg, 1959; Westphal, 1971), efforts were made to determine the 
free steroid levels in these immunized animals. Methods described 
for the determination of the free hormone fraction in plasma are 
generally based on equilibrium dialysis which is considered to be 
the most reliable technique as pointed out by Westphal (1971) and 
Kurz et al. (1977). However, the use of radiolabelled hormones makes 
this method less suitable for the measurement of the free fraction 
in plasma samples with a relatively high binding level. The minimal 
amounts of radioactivity present in the dialysate after equilibrium 
dialysis of such plasmas are a considerable source of error. This 
is particularly the case in plasmas of animals actively immunized 
against steroid-protein conjugates as demonstrated by Nieschlag et 
al. (1974), Hillier et al. (1975) and Haack et al. (1979). It 
appeared from these studies that equilibrium dialysis using radio-
labelled hormones was not sufficiently sensitive for detecting 
small changes in binding at levels exceeding 99%. Nor was this 
method precise enough to allow calculation of the free hormone 
concentration from the total concentration and the percentage 
binding. Criticism concerning the applicability of this equilibrium 
dialysis technique for the determination of the free hormone con-
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centration in actively immunized animals has also been voiced by 
Nieschlag et al. (1975), Thorneycroft et al. (1975) and Wickings and 
Nieschlag (1978). It has been concluded that all studies involving 
active immunization against steroids lack a sensitive and reliable 
method for the determination of the free hormone fraction, so that 
an accurate assessment of the free concentration has not been achie-
ved to date. 
In this Chapter an equilibrium dialysis method for the determina-
tion of the free aldosterone concentration in sheep plasma is re-
ported which circumvents the use of radiolabelled aldosterone and is 
independent of the binding level of the hormone. This method consists 
of equilibrium dialysis of a plasma sample and direct radioimmunolo-
gical determination of the free aldosterone present in the dialysate 
after equilibrium has been reached. The specificity and reliability 
of this combined equilibrium dialysis and radioimmunoprocedure is 
tested in dialysates of plasmas obtained from normal sheep. 
The radioimmunoprocedure used in the equilibrium dialysis method 
is a modification of the radioimmunoassay developed for the measure-
ment of total aldosterone directly in human plasma. This direct 
radioimmunoassay was applied since the radioimmunoassay for aldoste-
rone described in Chapter 1 was not suitable for this purpose. The 
extraction and purification procedure of this assay require large 
quantities of plasma to be dialyzed to obtain an amount of free 
aldosterone which could be reliably measured. 
The direct radioimmunoassay of aldosterone in human plasma is 
described in the present study and evaluated for specificity and 
reliability. Both extraction and purification can be eliminated in 
this assay by using a highly specific antiserum together with 
8-anilino-l-naphtalene-sulfonic-acid (ANS) as an agent to inhibit 
binding of aldosterone to plasma proteins. The properties of the 
antiserum, obtained by immunizing sheep against aldosterone-(18, 21) 
-diacetate-3-carboxymethyloxime-BSA, are described. 
MATERIALS AND METHODS 
Reagents 
The standards of unlabelled aldosterone and Cortisol and aldoste-
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rone-(18, 21)-diacetate-3-carboxymethyloxime-BSA, were from 
Steraloids. ANS was obtained from Merck. The antiserum used for 
assay of plasma Cortisol, raised in a rabbit against Cortisol 
21-hemisuccinate-BSA was a generous gift from dr. Vecsei (Pharma­
cological Institute, University of Heidelberg). The other materials 
used have been described in Chapter 1. 
Animals 
Texel White ewes were fed a normal diet with unrestricted access 
to food and water. For determination of total and free plasma 
aldosterone blood was collected from the jugular vein. Plasma was 
separated by centrifugation at room temperature and stored at -20oC 
until assayed. 
Immunization 
Three sheep were immunized with aldosterone-(18, 21)-diacetate-
3-carboxymethyloxime-BSA. Approximately 1.5 mg of the conjugate, 
emulsified with Freund's complete adjuvant, was used for initial 
injection. Boosters of 1 mg were given at varying intervals for 
seven months. Blood samples were taken from the jugular vein and 
allowed to clot for 2h. The serum, obtained after 20 min centrifu­
gation at 3000 rpm at room temperature, was tested for titre, speci­
ficity and affinity (as described in Chapter I) and stored at -20oC. 
Preparation of steroid-free plasma 
One hundred ml plasma were incubated under continuous stirring 
for 24h at 40C with 16g charcoal. After centrifugation at 
25,000 χ g for Ih (40C), the supernatant was collected and filtered 
over a glass filter. Microscopic examination of the final sample did 
not reveal any residual charcoal particles. If Η-aldosterone was 
added to plasma prior to extraction it was completely removed by 
this procedure. 
Total plasma aldosterone 
Levels of total aldosterone in sheep plasma were determined by 
radioimmunoassay. Measurements were performed after extraction and 
paper chromatography, in the Bush B 5 system, of 2 ml plasma using 
an antiserum raised in sheep against aldosterone 21-monohemisucci-
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nate-BSA (S83). The antibody-bound and free fraction were separated 
by dextran-coated charcoal. Details of this radioimmunoassay have 
been described in Chapter I. 
Immunochromatoqrams 
Nine ml of pooled sheep plasma were dialyzed against nine ml 
phosphate buffer (pH 7.4) for 18h at 370C. After the addition of 
^H-aldosterone (10.000 dpm) 7 ml of the dialysate were extracted 
with dichloromethane and chromatographed in the Bush B^ system. 
Three ml of pooled human plasma were incubated with Зн-aldosterone 
(10.000 dpm) for 30 min at room temperature, extracted with di­
chloromethane and chromatographed in the Bush B 5 system. After 
developing the chromatogram for 4 h, the paper was cut into 1 cm 
strips and each strip eluted with 1 ml 0.2% ethylene glycol, 
150 μΐ was counted for radioactivity and 2x 300 yl were radioimmuno-
assayed using antiserum S85. Immunoactivity was read from the 
standard curve as was used in the method described in Chapter I, 
that is without addition of ANS. 
Equilibrium dialysis 
Equilibrium dialysis was carried out using a "Dianorm equilibrium 
dialyser" (Diachema A.G., Switzerland). In this system a semi­
permeable membrane divides a teflon dialysis cell into two identical 
compartments. The plasma is pipetted into one half-cell and the 
buffer into the other. The ready made membranes (Diachema type 
10.14, molecular weight cut-off 5000) are first soaked and washed 
with distilled water and then rinsed in dialysis buffer (phosphate 
0.15M pH 7.4). 
RIA method Determination of the free aldosterone concentration 
in sheep plasma by equilibrium dialysis using the direct radio­
immunoassay, was performed in cells with a working volume of 2x 1 ml 
and a membrane area of 4.5 сш^. One ml of plasma was dialyzed 
against 1 ml of the phosphate buffer for 18 h at 370C with conti­
nuous rotation of the cells. At the end of this period duplicate 
aliquots of the dialysate (300 μΐ) were directly assayed by radio­
immunoassay. 
Tracer method Determination of the free aldosterone fraction in 
sheep plasma by equilibrium dialysis using radiolabelled aldosterone, 
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was performed in microcells with a working volume of 2x 200 μΐ and 
a membrane area of 2 cm^. The 3H-aldosterone was purified by paper 
chromatography in the Bush B^-system, eluted in phosphate buffer 
and used. A plasma sample of 190 μΐ was dialyzed against 190 μΐ 
phosphate buffer, containing approximately 100.000 dpm of purified 
3H-aldosterone, for 18h at 370C under continuous rotation. Following 
the dialysis, 100 μΐ of the dialysate was pipetted into counting 
vials and counted for radioactivity. The free fraction was calcula­
ted by the following formula: 
C2 
Free fraction(%) = χ 100 
C
o -
 c2 
where: C2 = radioactivity in dialysate (cpm/ΙΟΟμΙ) 
C 0 = radioactivity in phosphate buffer (cpm/ΙΟΟμΙ) 
The free aldosterone concentration can be calculated after deter­
mining the total aldosterone concentration: 
Free concentration = Free fraction (%) χ Total concentration χ IO-2 
The precision of the tracer method was estimated by repeated deter­
minations of a normal sheep plasma on different days (inter-assay). 
The mean percentage free was 43.2 (n=ll) with a coefficient of 
variation of 6.9%. The coefficient of variation within one assay 
(intra-assay) for the same sample was 6.4% (n=19). 
Plasma study To study the distribution of labelled aldosterone 
over (human) plasma binding proteins and antibody under simulated 
radioimmunoassay conditions, microcells with a working volume of 
2x 200 μΐ and a membrane area of 2 cm2 were used. One compartment 
was filled with 190 μΐ antiserum S85 diluted 1:32.000 in 0.05 M 
borate buffer, pH 8.6 containing 0.1% human γ-globulin, in which 
ANS was dissolved (0.16% or 0.48%), or omitted. The other compart­
ment contained 95 μΐ H-aldosterone (10.000 dpm), diluted in the 
same buffer as the antiserum and 95 μΐ of a low Cortisol plasma 
(3 μg/100 ml) with or without added Cortisol (5-30 μg/100 ml plasma). 
After equilibration for I8h at 40C, radioactivity in both compart­
ments was measured. 
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Immunoassays 
Dialysate assay The total volume of the incubation medium was 
700 μΐ consisting of 300 ul sheep plasma dialysate or 0.15M phosphate 
buffer pH 7.4 (for standards), 100 μΐ 0.2% ethylene glycol with or 
without standard (0-80 pg aldosterone), 100 yl steroid-free sheep 
plasma, 100 μΐ H-aldosterone (6000 dpm) and 100 μΐ antiserum S85 
(1:14.000). Tracer and antiserum are both dissolved in 0.05M borate 
buffer pH 8.6 containing 0.1% human γ-globulin and 0.85% ANS. After 
incubation for 18h at 40C, bound and free fractions were separated 
by addition of 150 yl 6.25% charcoal (contact time: 6 min.) and 
centrifugation for 10 min. at 10.000 g (40C). The supernatant was 
decanted and counted for radioactivity. Technical details of the 
separation procedure have been described in Chapter 1. 
D-ireat plasma assay The incubation medium consisted of 100 yl 
human plasma or steroid-free plasma (for standards), 100 μΐ 0.2% 
ethylene glycol with or without standard (0-320 pg aldosterone), 
100 μΐ 3H-aldosterone (6000 dpm in 0.05 M borate buffer pH 8.6, con­
taining 0.1% human γ-globulin) and 300 μΐ antiserum S85 (1:48.000) in 
the same buffer, containing 0.48 ANS. After incubation for 18h at 
40C, bound and free fractions were separated by addition of 150 μΐ 
6.25% charcoal (contact time: 6 min.) and centrifugation for 10 min. 
at 10.000 χ g (40C). The supernatant was decanted and counted for 
radioactivity. Technical details of the separation procedure were 
described in Chapter 1. 
Cortisol assay Essentially the radioimmunoassay for Cortisol was 
performed according to Vecsei (1974). Plasma samples were diluted 
(1:100) with 5% ethanol and 100 μΐ was brought to 70oC for Ih in a 
stoppered test tube. Standard solutions (15-300 pg in 100 μΐ 5% 
ethanol, 1% steroid free plasma) were treated identically. After 
incubation the tubes were placed in ice and 100 μΐ ^H-cortisol 
(10.000 dpm) and antiserum K14 (1:15.000) were added, both in a 
buffer containing 0.1% lysozyme, 0.IM KCl and 0.05M HjBOß, pH 8.0. 
After mixing the tubes were incubated for 15 min at room tempera-
ture and, subsequently for 18h at 40C. Bound and free fractions 
were separated by addition of 100 μΐ dextran-coated charcoal (0.9% 
charcoal, 0.11% dextran in 0.1% beriglobin, 0.1M KCl and 0.05M 
H3BO3, pH 8.0). Contact time was 3 min. and after centrifugation 
for 10 min. at 9000 χ g (40C) the supernatants were collected by 
décantation and counted for radioactivity. 
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Calculation 
The free plasma aldosterone concentration was calculated from 
the values of the total plasma aldosterone concentration and the 
aldosterone concentration in the dialysate by the following formula: 
H
o 
F_ = 
О н 0 - v t + 1 
F V 
where: F = free plasma aldosterone concentration (ng/100 ml) 
H = total plasma aldosterone concentration (ng/100 ml) 
F = aldosterone concentration in the dialysate (ng/100 ml) 
V- = volume of original plasma sample (ml) 
V t = total volume of dialysis system (ml) 
The free aldosterone fraction was expressed as percentage of the 
total plasma aldosterone concentration using the formula: 
Free concentration 
Free fraction (%) = χ 100 
Total concentration 
RESULTS 
Production and characterization of antisera 
All three animals produced antibodies against the aldosterone 
immunogen. The titres for the antisera are shown in Fig.2.1; the 
highest titres were obtained 32 weeks after primary immunization. 
All three antisera showed similar characteristics with respect to 
titre and cross reactivity. The antiserum utilised in the assay 
described was obtained from sheep 85 at a final dilution of 
1:96,000. Antibody binding data obtained using antiserum of sheep 
85 under the circumstances previously described were replotted 
according to the method of Scatchard (1949). The plot obtained was 
curvilinear which indicates the presence of different classes of 
antibodies. The average affinity constant calculated from the linear 
part of the plot was 9.0 χ IO9 litres/mol. 
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Evaluation of the direct assay for aldosterone in human plasma 
Standard curve A typical curve of the assay, obtained in the 
presence of steroid-free plasma is shown in Fig. 2.2. The minimum 
detectable dose of aldosterone was estimated by reading off twice 
the S.D. of the zero points of the standard curve. In this case 2.0 
pg of aldosterone was distinguishable from zero. This corresponds 
to an aldosterone concentration of 2.0 ng/100 ml plasma. 
Specificity The percentage of cross reactivity of the antiserum 
S85 with various steroids is shown in Table 2.1. Specificity was 
further tested by immunochromatographic analyses of a pooled plasma 
sample. Fig. 2.3 shows the immunochromatogram obtained while using 
antiserum S85. These results indicate the extremely high specificity 
of the antiserum. 
Table 2.1 Cross reactivity of antiserum S85. 
Steroid Percentage of 
cross reaction 
100 
< 
< 
< 
< 
< 
< 
< 
< 
30.0 
0.84 
7.64 
0.50 
0.004 
0.004 
0.004 
0.004 
0.58 
1.00 
0.06 
0.13 
0.004 
0.004 
0.004 
0.004 
Aldosterone 
Aldosterone 21-monoacetate 
Aldosterone 18, 21-diacetate 
17-Iso-aldosterone 
Aldosterone-y-lactone 
Cortisone 
Cortisol 
11-Deoxycortisol 
21-Deoxycortisol 
Corticosterone 
11-Deoxycorticosterone 
Testosterone 
Progesterone 
9a-Fluorocortisol 
Aldadiene 
Potassium canrenoate 
Spironolactone 
All steroids were obtained from Steraloids 
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antibody t i t r e 
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15 10 2 0 25 3 0 35 
weeks after primary immunization 
Fig. 2 Л Titres of the antisera raised in sheep 85 
( ), 93 ( ) and 56 ( ) against 
aldosterone-1Θ, 21-diacetate-3-carboxymethyloxime-BSA. 
I I I I I I I I I I I I I I I I -
4 0 ΘΟ 120 160 2 0 0 2 4 0 2Θ0 320 
aldosterone added to steroid-free plasma (pg) 
Pig. 2.2 Standard curve for the 
direct radioimmunoassay of 
aldosterone. Points are mean values 
and brackets indicate the standard 
deviation (n=6). 
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pg 
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зо 
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cpm 
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10 
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distance from origin (err,) 
Fig. 2.3 Iramunochromatographic analys i s of human 
plasma employing antiserum 385. Plasma was i n ­
cubated with -'H-aldosterone, ex t racted and chroma-
tographed. The chromatogram was divided i n t o 1 cm 
s t r i p s which were, a f te r e l u t i o n , assayed for 
immunoactivity ( ) and r a d i o a c t i v i t y ( ) . 
Correlation with other method The a l d o s t e r o n e c o n t e n t of 44 
plasma samples was measured, both by t h e d i r e c t assay and by the 
method u s i n g e x t r a c t i o n and chromatography p r i o r t o radioimmunoassay 
(Chapter 1 ) . The concordance between t h e s e two methods (Fig . 2.4) 
was h i g h l y s i g n i f i c a n t . 
direct assay ( ng /100 ml ) -
120 
100 -
Θ0 
6 0 
40 -
2 0 y= 103χ·246 
г =098 
η = 44 
1 1 1 1 1 
20 40 60 ΘΟ 100 120 
assay after extraction and chromatography 
(ng/100m0 
Fig. 2.4 Comparison of results 
obtained by direct aldosterone 
assay with those after extrac­
tion and chromatography. 
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Aaouvaoy The accuracy of the assay was tested by examining the 
recovery of increasing various amounts of aldosterone added to a 
pooled plasma sample. Fig. 2.5 shows excellent agreement between 
aldosterone recovered and added. 
Dilution study A high aldosterone plasma was serially diluted 
with steroid-free plasma and the aldosterone level was assayed. 
A linear relation was observed between sample dilution and aldoste­
rone concentration (Fig. 2.6). 
aldosterone recovered (pg) -
200 • 
160 
120 
Θ0 
4 0 y = 0 9 4 x . 2 1 3 
г = 099 
— ι 1 1 1 
40 Θ0 120 160 200 
aldosterone added (pg) 
Fig. 2.5 Accuracy of the d i r e c t 
radioimmunoassay of a ldos terone. 
Increasing amounts of aldosterone 
standard were added to human plasma 
and the samples were assayed d i r e c t l y . 
aldosterone (ng/ЮО ml) -
100 π 
6 0 
40 -
2 0 -
/ / r = 0 9 9 
02 04 06 08 10 
dilution"1 
Fig. 2.6 Parallelism in the direct 
radioimmunoassay of aldosterone. A 
high aldosterone plasma was serially 
diluted with steroid-free plasma and 
the dilutions were assayed directly. 
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Précision Intra-assay and inter-assay reproducibility was 
examined by assay of a normal (6.9 ng/100 ml) and a high aldosterone 
pooled plasma (30.1 ng/100 ml). The intra-assay coefficient of 
variation was 14.3% (n=8) in normal pool plasma and 4.5% (n=8) in 
high aldosterone pooled plasma. Corresponding values were obtained 
for the inter-assay coefficient of variation: 14.0% and 8.5%, res-
pectively (n=10). 
Aaeay blank The aldosterone level in a blood sample from an 
adrenalectomised patient was assayed to examine the blank. The aldos-
terone value of this sample was below the limit of detection. 
The effect of ANS All results described so far were obtained 
with 0.24% ANS in the radioimmunoassay medium. Its presence pre-
sumably prevents the interaction between aldosterone and plasma 
proteins. Conceivably such interaction may affect the assay results 
by preventing part of the aldosterone from binding to the antibody. 
The effect of ANS appears to be related to the plasma Cortisol con-
centration. In 10 plasmas low in Cortisol (< 5 ug/lOO ml), the 
values measured by direct assay in the absence of ANS were signi-
ficantly higher than those found after an assay including extraction 
and chromatography (Fig. 2.7A). Increasing amounts of ANS appeared 
to reduce this difference and at a final concentration of 0.24% ANS 
the results of the direct assay came very close to the values of the 
assay after purification. Fig. 2.7B depicts the same experiment with 
9 plasmas with a higher Cortisol level (> 10 ug/100 ml). In this 
case the results of the direct assay were identical to those obtained 
after extraction and chromatography, regardless of the presence or 
absence of ANS. 
Effect of Cortisol To investigate the cause of the high aldoste-
rone levels measured in low Cortisol plasmas in the absence of ANS, 
diluted antiserum was dialysed against aldosterone tracer in a low 
Cortisol plasma (3 yg/100 ml) in the presence of increasing amounts 
of Cortisol. The incubation conditions were similar to those in the 
radioimmunoassay and the experiment was repeated with different ANS 
concentrations (Fig. 2.8). In the absence of ANS, Cortisol affected 
the amount of aldosterone tracer in the antiserum compartment. At a 
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plasma aldosterone (ng/ЮО ml) -
1 0 0 -
Fig. 2.7 Effect of ANS on the 
results of the direct aldosterone 
radioinmunoassay. The human plasmas 
low in Cortisol (< 5 yg/100 ml, 7A) 
and nine human plasmas with a relati­
vely high Cortisol level (> 10 lig/ 
100 ml, 7B) were assayed with a direct 
radioinmunoassay without ANS, a direct 
radioimmunoassay with ANS and a radio­
immunoassay performed after prior 
extraction and chromatography. 
without ΟΟβ·/ο 0 2 4 · / . after 
ANS ANS ANS chromato­
graphy 
% 3H-aldosterone in antiserum compartment -
6 0 π 
5 0 
4 0 
3 0 
2 0 -
10 
У 
. / 
/ 
without ANS 
ΟΟΘ·/. ANS 
0 2 4 % ANS 
— ι 1 1 г 
10 2 0 3 0 4 0 
Plasma Cortisol (лід/ЮО ml ) 
Fig. 2.8 Effect of Cortisol on the 
distribution of 3H-aldosterone over 
plasma binding proteins and antibody 
under RIA conditions. The percentage 
3H-aldosterone in the antiserum 
compartment was determined after 
equilibrium dialysis against aldoste­
rone tracer in human plasma with 
increasing Cortisol levels with and 
without the addition of ANS. 
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final concentration of 0.08% ANS this effect was still present. 
However, the %3H-aldosterone was independent of the Cortisol level 
in the presence of 0.24% ANS. This concentration was routinely 
employed in the radioimmunoassay. 
Evaluation of the assay for free aldosterone in sheep plasma 
Standard curve The standard curve was prepared using from 
0-80 pg of aldosterone. A typical standard curve is shown in Fig. 
2.9. Using a 1:14,000 dilution of the antiserum the mean initial 
binding of 18 pg 3H-aldosterone was 47.1 + 3.8(SD)%, n=14. 
Specificity The percentage of cross reactivity of the antiserum 
S85 with various steroids is shown in Table 2.1. Despite excellent 
specificity immunochromatographic analysis of a pooled plasma 
dialysate showed the presence of other cross reacting steroids 
(Fig. 2.10). It appears from these results that aldosterone cannot 
be simply radioimmunoassayed in sheep plasma dialysates. 
Fig. 2.9 Standard curve for the 
direct radioimmunoassay of aldosterone 
in sheep plasma dialysates. Points are 
mean values and brackets indicate the 
standard deviation (n=6) . 
60 80 
aldosterone (pg) 
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Fig. 2.10 Immunochromatographic analys is of sheep plasma d i a l y s a t e 
a f t e r equilibrium d i a l y s i s employing antiserum S85. After the 
addi t ion of 3 H-aldosterone the d i a l y s a t e was extracted and chromato-
graphed in the Bush Bç-paper system. The chromatogram was divided 
in to 1 cm s t r i p s which were, a f t e r e lu t i on , assayed for immuno-
a c t i v i t y ( ) and r ad ioac t iv i ty ( ) . 
Indeed, d i rec t measurement in plasma dia lysates yielded spuriously 
elevated values as compared with the r e su l t s obtained in the same 
dia lysa tes af ter extract ion and paper chromatography. Surprisingly, 
when the d i r ec t assay on plasma dialysates was performed under the 
same conditions as the d i r ec t assay in human plasma ( i . e . with 
s te ro id- f ree plasma and ANS) the r e su l t s agreed very well with 
those af ter extract ion and chromatography (Fig. 2.11). 
direct assay (ng/TOOml) • 
2 0 τ 
10 -
10 2 0 
assay after extraction and chromatography 
(пдПООтІ) 
Fig. 2.11 Aldosterone concentration in 
sheep plasma dialysates. Comparison of 
values obtained by direct assay with 
those measured after extraction and 
chromatography. 
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Correlation with tracer method The results obtained by the 
present RIA method were compared with those obtained by the equili­
brium dialysis method using radiolabelled aldosterone. When the 
same plasma samples were measured by both methods a highly signifi­
cant correlation was obtained as shown in Fig. 2.12. 
tree plasma aldosterone(ng/1O0ml)-
measured by RIA-method 
6 -
π 1 1 1 1 1 г г 
2 4 6 θ 10 
free plasma aldosterone (ng/100 ml) 
measured by tracer-method 
Fig. 2.12 Correlat ion of free 
aldosterone values in sheep plasma 
obtained by radioinununoassay with 
those determined by equilibrium 
d i a l y s i s using radio labe l led 
a ldosterone. 
Precision The p r e c i s i o n of t h e measurements of f ree a l d o s t e r o n e 
in plasma d i a l y s a t e by t h e combined e q u i l i b r i u m d i a l y s i s and r a d i o -
immunoprocedure was a s s e s s e d by t e s t s for i n t r a - en i n t e r - a s s a y 
v a r i a b i l i t y . The i n t r a - a s s a y v a r i a b i l i t y was e v a l u a t e d by r e p l i c a t e 
d e t e r m i n a t i o n s i n t h e same assay of plasma d i a l y s a t e s c o n t a i n i n g 
low and normal c o n c e n t r a t i o n s of a l d o s t e r o n e . The mean v a l u e s were 
1.0 ng/100 ml (n=10) and 6.9 ng/100 ml (n=10) wi th c o e f f i c i e n t s of 
v a r i a t i o n of 24.7% and 7.9%, r e s p e c t i v e l y . For t h e d e t e r m i n a t i o n of 
t h e i n t e r - a s s a y v a r i a b i l i t y , d u p l i c a t e measurements were performed 
in two d i f f e r e n t a s s a y s . The c o e f f i c i e n t of v a r i a t i o n (CV) of t h e s e 
r e s u l t s was e s t i m a t e d by t h e fol lowing formula: 
2Ыі - X2) 2 
Ζ χ 100 
cv = 
(χ, + x 2 ) 
2n 
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where: х^, X2 = corresponding duplicate values 
η = number of duplicate pairs 
In 20 duplicate determinations in two different assays, with 
values ranging from 0.5 - 6.1 ng/100 ml, the coefficient of varia­
tion was 21.2%. 
Blank of method and sensitivity In the routine analysis two 
samples of a steroid-free plasma dialysate are included in each 
assay. The mean percentage binding of 18 pg ^Η-aldosterone was 
49.8 + 3.6(SD)%, n=12, which indicates in these cases a negative 
blank value. The mean aldosterone content of these samples was 
-3.9 + 1.2(SD)pg, n=12. In each assay the samples were corrected 
for the blank value obtained. 
The sensitivity of the radioimmunoassay can be expressed as 
twice the intra-assay standard deviation of the blank. Since the 
standard deviation was + 0.7 pg, the detection limit is 1.4 pg 
which equals a dialysate concentration of 0.5 ng/100 ml. For a 
plasma sample with a free aldosterone fraction of 40% this dialysate 
concentration corresponds with a free aldosterone concentration of 
0.6 ng/100 ml. 
(гее plasma aldosterone ( ng/lOO ml) 
τ — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — ι — r - 1 
2 4 6 β 10 12 14 16 1Θ 20 
total plasma aldosterone (ng/100 ml) 
Fig. 2.13 Relation between the free and total plasma aldosterone 
concentrations in normal sheep. 
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Animal studies The mean free aldosterone level in 18 normal 
sheep was 1.8 + 1.2(SD) ng/100 ml (range 0.4 - 5.4 ng/100 ml) 
measured by the present method in blood samples taken on six con­
secutive days between 9 and 11 a.m. The mean total plasma aldoste­
rone concentration of these animals was 4.6 + 3.2(SD) ng/100 ml 
(range 0.9 - 13.0 ng/100 ml) indicating a mean percentage free 
aldosterone of 41.6 + 5.7. In Fig. 2.13 the results are shown of 
the concentrations of free and total aldosterone determined in nor­
mal sheep over a sampling period of almost one year under conditions 
described for control animals in Chapter 3. 
DISCUSSION 
The majority of the radioimmunoassays developed for the measure­
ment of aldosterone in plasma require an initial purification step 
before the immunoassay can be performed. This step is necessary 
because of the lack of specificity of the antisera raised against 
aldosterone. Various techniques have been used for the separation 
of aldosterone from other interfering steroids. Paper chromato­
graphy is used in many assays (Bayard et al., 1970; Mayes et al., 
1970; Ekins et al., 1972; Ito et al., 1972; Underwood et al., 1972) 
as well as column (Mayes et al., 1970; Ito et al., 1972; Castro 
et al., 1974; Daniel et al., 1974) and thin-layer chromatography 
(StCyr et al., 1972; Kurtz et al., 1976; Parth et al., 1976; 
Scandrett et al., 1976). Purification of plasma extracts has also 
been achieved by liquid-liquid partition and subsequent periodate 
oxidation of aldosterone to the corresponding γ-lactone (Farmer 
et al., 1973; Varsano-Aharon et al., 1973) and by immunological 
methods (Gomez-Sanchez et al., 1973; Martin and Nugent, 1973). 
Highly specific antisera made it possible to simplify the radio­
immunoassay for plasma aldosterone. Methods were developed which 
avoid purification by measuring aldosterone directly in plasma 
extracts (Vetter et al., 1973; McKenzie and Clements, 1974; 
Pham-Huu-Trung and Corvol, 1974; Hubl et al., 1975; Malvano et al., 
1976; Lijnen et al., 1978). Although these direct assays are 
simpler and less time consuming they still require an initial ex­
traction procedure and individual recovery estimates. To avoid 
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this complication a number of radioimmunoassays have recently been 
developed which enable the direct measurement of aldosterone in 
unextracted plasma (Ogihara et al., 1977; Al-Dujaili and Edwards, 
1978; Connolly et al., 1980; Pratt et al., 1978). There are two 
major requirements for such a direct radioimmunoassay. First, the 
availability of an aldosterone antiserum with high sensitivity and 
specificity. Second, a procedure to convert the aldosterone bound 
to plasma proteins into free aldosterone. Since part of the circu-
lating aldosterone is bound to plasma proteins (Zipser et al., 
1980) and such interaction might interfere with the assay. The 
antisera used in the direct assays of plasma aldosterone in plasma 
extracts or unextracted plasma have been raised against protein 
conjugates of aldosterone-3-carboxymethyloxime (Vetter et al., 
1973; McKenzie and Clements, 1974; Ogihara et al., 1977; Al-Dujaili 
and Edwards, 1978; Connolly et al., 1980), aldosterone 21-mono-
hemisuccinate (Hubl et al., 1975) and aldosterone-(18, 21)-diaceta-
te-3-carboxymethyloxime (Pham-Huu-Trung and Corvol, 1974; Malvano 
et al., 1976; Lijnen et al., 1978; Pratt et al., 1978). In our 
hands antisera against the latter immunogen were superior in 
specificity to those elicited by the former two conjugates. Disso-
ciation of the aldosterone-protein binding can be obtained by 
heating the plasma sample as described by Connolly et al. (1980) 
in a direct radioimmunoassay of unextracted plasma. Other investi-
gators displaced aldosterone by a large excess of Cortisol (Pratt 
et al., 1978) or blocked the aldosterone-protein binding by means of 
8-anilino-l-naphtalene-sulfonic acid (Ogihara et al., 1977). How-
ever, Al-Dujaili and Edwards (1978), who used no such treatments 
reported an excellent correlation between the results of their 
direct assay and the levels measured after paper chromatography 
or extraction. 
The requirement of compatibility of standards and unknowns 
is inherent to any radioimmunoassay. Often this requirement is 
readily fulfilled when the substance to be measured is isolated 
prior to the actual assay. In a direct assay such as described here, 
steroid free plasma is added to the solutions used for the standard 
curve, to ascertain assay conditions closely approximating those 
of the unknowns. 
It appears from this study that this approach is not always 
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successful even when a highly specific antiserum is used. In 
addition to ligands that compete with the hormone for sites on the 
antibody, binding proteins present in the plasma samples may also 
have various adverse effects. Not only the concentration of these 
binding sites may vary from sample to sample but also the availa­
bility of the binding sites for the hormone. This availability is 
a function of both the concentration of binding protein and the 
concentration of ligands competing for these sites. One may expect 
that in such a case the addition of agents which prevent hormone 
binding to these plasma proteins will be effective in eliminating 
this type of interference. Our results indicate that the need for 
ANS in the assay medium is related to the plasma Cortisol level. 
If plasma Cortisol is higher than 10 ug/100 ml, the result of the 
direct assay without ANS is not significantly different from the 
value obtained after chromatography (Fig. 2.7B). If plasma Cortisol 
is lower than 5 yg/100 ml, the direct assay in the absence of ANS 
results in significantly higher levels for aldosterone than obtained 
in the reference method (Fig. 2.7A). The dependence of the assay 
results on the plasma Cortisol level could be ascribed to the 
available transcortin binding sites for aldosterone which vary 
with the Cortisol concentration. If Cortisol is present in 
sufficiently high concentration it displaces aldosterone, thereby 
making the presence of ANS superfluous. On the other hand, if plasma 
Cortisol is low an additional displacing agent is needed to prevent 
the aldosterone-transcortin interaction. The observation of the 
apperent elevation of aldosterone levels in low Cortisol plasmas, 
when no ANS is present in the assay, may be explained by the 
binding of labelled and unlabelled aldosterone to transcortin sites 
at the expense of binding to antibody. During the separation step 
the tracer is then removed from this plasma protein by the charcoal 
and ends up in the free fraction. This could then result in a 
spuriously low radioactivity in the bound fraction and therefore in 
erroneously high values for plasma aldosterone. This hypothesis is 
supported by the results of the dialysis experiment (Fig. 2.8). The 
binding of ^Η-aldosterone to the antiserum is affected by the 
Cortisol level. In the absence of ANS only 18% of the labelled 
aldosterone is found in the antiserum compartment, presumably 
because of the aldosterone binding capacity of the plasma proteins 
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in the other compartment. Increasing amounts of Cortisol displace 
Зн-aldosterone from these proteins, thereby augmenting the concen­
tration available for binding to the antiserum. The presence of 
0.24% ANS prevents the binding of ^H-aldosterone to clasma proteins 
and thus Cortisol does not affect the amount of H-aldosterone 
measured in the antiserum compartment anymore. As is shown in 
Fig. 2.8 the level of -^H-aldosterone measured in the antiserum 
compartment, in the presence of 0.24% ANS, is higher that that 
obtained without ANS or with 0.8% ANS, in the presence of a high 
Cortisol concentration. This difference might be due to the 
aldosterone-albumin interaction; in contrast with ANS, Cortisol 
would be unable to displace aldosterone. 
In conclusion to obtain reliable results for plasma aldosterone 
by direct radioimmunoassay, addition of ANS or a similar agent is 
required. It should be pointed out that this applies to our assay 
conditions, using our antiserum S85. It is conceivable that in 
another assay using a different antiserum with other affinity 
characteristics, the problem may not exist in this form. However, 
one should be aware of possible interference by Cortisol when 
setting up a direct radioimmunoassay for plasma aldosterone. 
The method for the determination of free aldosterone in sheep 
plasma described in this study has proven to be useful for this 
purpose. The main advantage of this method is that no radioactive 
aldosterone is introduced in the equilibrium dialysis system. The 
free concentration is determined by measuring the amount of free 
aldosterone, present in the dialysate, directly by radioimmunoassay. 
All equilibrium dialysis techniques described for the determination 
of the free aldosterone concentration in human plasma use radio­
active aldosterone for the measurement of the free hormone fraction 
(Sandberg et al., 1960; Meyer et al., 1961; Zager et al., 1976; 
Zipser et al., 1980). In general the use of tracers in an 
equilibrium dialysis system suffers from an important drawback. A 
certain degree of radiolysis may occur, both before and during the 
experiment. In fact commercially available tritium-labelled 
steroids have only a degree of purity of 96-99%. In the case of 
aldosterone with a free fraction of 41.6% as determined in this 
study in normal sheep plasma the effect of these tracer impurities 
is small. However, in plasmas with higher levels of binding 
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proteins, 1-4% degraded tracer impurities represent a considerable 
source of error. Frequent chromatographic purification of the 
tracer will reduce but not entirely eliminate this error. 
Despite the rather high specificity of the antiserum used in 
the radioimmunoassay, the amount of cross reacting steroids present 
in the dialysate (Fig. 2.10) necessitates the separation of 
aldosterone from those steroids before the binding assay. These 
amounts were surprisingly high since in human plasma no steroids 
were detected with a significant high cross reactivity towards the 
antiserum, as shown by immunochromatographic analysis (Fig. 2.3). 
Besides, equilibrium dialysis lowers the amount of other 
steroids in the dialysate relative to the amount of aldosterone, 
since aldosterone is bound to a much lesser degree by plasma 
proteins than for instance Cortisol and corticosterone (Sandberg 
et al., 1965; Westphal, 1971). Despite this effect of equilibrium 
dialysis, cross reacting steroids are still present in sheep 
plasma dialysate. Separation of aldosterone from interfering cross 
reacting steroids is obtained by binding to plasma proteins 
(steroid-free plasma) and selective displacement of aldosterone 
by ANS. The mechanism by which the combination of steroid-free 
plasma and ANS exert their effect in the incubation medium is 
difficult to establish. As described by Westphal (1971) the affinity 
constants for the aldosterone-CBG complex are smaller than those 
of the corresponding corticosteroid-CBG complexes. But the binding 
affinity of CBG is not limited to the corticosteroids. Progesterone 
and testosterone interact also strongly at the same binding site. 
It is known that ANS is a useful agent to eliminate the binding of 
hormones to plasma proteins. We found, in our assay conditions, 
that ANS might displace aldosterone selectively from binding 
proteins, probably due to the lower affinity constant, while cross 
reacting steroids remain bound and thus do no compete for the 
binding sites on the antibody. Improvement of the specificity of 
the assay using steroid-free plasma and ANS, is demonstrated by 
the results obtained with samples purified by extraction and 
chromatography (Fig. 2.11). There was no systematic decrease in 
the aldosterone concentrations after purification. 
We found a non-specific immunoassay blank for dialysates 
obtained from steroid-free plasma. In our experience this blank 
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is the result of unknown substances in plasma which appear in the 
dialysate during dialysis. In order to obtain the same assay 
conditions for samples and standards, dialysate of steroid-free 
plasma should be added to the standard curve. For practical reasons 
we have chosen for a standard curve obtained in the presence of 
buffer since large amounts of steroid-free plasma would be needed 
and dialysis of this steroid-free plasma would be an additional 
time consuming step. Instead, we dialyse in each assay two steroid-
free plasma samples, measure the dialysates in the radioimmunoassay 
and correct the unknown sample for the mean value obtained for the 
steroid-free plasma dialysates. This procedure has been proven to 
be correct as indicated by comparing the values obtained with 
those determined by equilibrium dialysis using radiolabelled 
aldosterone (Fig. 2.12); the results are similar at any concentra­
tion of aldosterone. 
In conclusion, the proposed method appears to be a practical 
technique for the measurement of the free plasma aldosterone con­
centration in sheep. The method appears to be preferable for 
plasmas with a high binding level since the measurement of the 
free concentration is independent of the free aldosterone fraction. 
The assay method is particularly suitable for the determination of 
the free aldosterone concentration in plasma of sheep actively 
immunized against aldosterone-protein conjugates. 
Appendix 
When calculating the free steroid concentration in plasma one 
must take into account the change in volume of dialysate and plasma 
sample at dialysis equilibrium. According to Sandberg and Slaun-
white (1957) the free concentration (F0) can be calculated by the 
following formula: 
F 
Where: F = concentration free hormone 
В = concentration bound hormone 
H 0 = total hormone concentration 
In the course of equilibrium dialysis the plasma sample will 
become diluted with dialysate to a certain degree by the difference 
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of colloidal osmotic pressure between plasma and buffer. This does 
not influence the concentration of free hormone in the dialysant, 
since it has the same concentration as in the dialysate. The con­
centration of bound hormone, however, changes as a result of this 
dilution. It is possible to circumvent this problem by expressing 
the bound hormone in terms of total and free hormone. The amount 
of bound hormone is obviously equal to the difference between total 
and free hormone : 
B.V0 = H0.V0 - F.Vt 
Where: 
Hence, 3. 
V 0 = volume of original plasma sample 
V t = total volume of dialysis system 
Н
Л
. „ - F.V*. 
В = 
'Ό *
 v
 О 
If this is substituted in equation 1, the free concentration will 
be: 
4. 
F
o = 
v t + 1 
In conclusion, the free hormone concentration can be assessed from 
measurements of free and total hormone only and measurements in the 
dialysant are unnecessary. 
Formula 4 can be rearranged in order to obtain an expression for 
the free hormone fraction as used for the tracer method. Division 
of both sides by H 0 gives: 
5. Free fraction = 
v t + 1 
Since the ratio of total and free concentrations (H0/F) is equal to 
the ratio of radioactive concentrations C0/C2 equation 5 becomes: 
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Free fraction = 
CQ - Vt + ι 
Where: C2 = radioactivity in dialysate 
C 0 = radioactivity in phosphate buffer 
C2 
-o -
 c
; 
Which, since Vt/V0 = 2, equals: 
7. Free fraction = 
SUMMARY 
An equilibrium dialysis method for the determination of the 
free aldosterone concentration in sheep plasma is described which 
circumvents the use of radiolabelled aldosterone by direct radio-
immunological measurement of the free hormone concentration in the 
dialysate. The direct radioimmunoassay is a modification of the 
assay developed for the measurement of total aldosterone directly 
in human plasma using a highly specific antiserum raised in sheep 
against aldosterone-(18, 21)-diacetate-3-carboxymethyloxime-BSA. 
The specificity and reliability of this radioimmunoassay is 
described and the necessity of including a blocking agent to inhibit 
the binding of aldosterone to plasma proteins was investigated. It 
was found that in low Cortisol (< 5 yg/100 ml) plasmas the absence 
of such an agent, 8-anilino-I-naphthalene-sulphonic acid (ANS), led 
to erroneously high estimates of plasma aldosterone. At higher 
Cortisol concentrations (> 10 yg/lOO ml) the final assay result was 
independent of the presence of ANS. The effect of Cortisol was 
interpreted in terms of its impact on aldosterone binding to plasma 
proteins in the absence of a blocking agent. 
The method for the determination of the free aldosterone concen­
tration in sheep plasma implies equilibrium dialysis of a 1 ml 
plasma sample against 1 ml of phosphate buffer, pH 7.4, for I8h at 
370C, followed by direct radioimmunoassay of aldosterone in the 
buffer solution. The concentration of free aldosterone in plasma 
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is calculated from this concentration of dialysable aldosterone 
and the total plasma aldosterone concentration. The formula used 
for this calculation takes into account the changes in the volume 
of plasma and buffer during dialysis. The specificity, precision 
and sensitivity of the method were assessed in dialysates of normal 
sheep plasma. Specificity is improved by measuring aldosterone in 
the presence of steroid-free plasma and ANS. Specificity was con­
firmed by comparing the results with those obtained after extraction 
and chromatography. There was an excellent correlation between the 
present method and an equilibrium dialysis method using radio-
labelled aldosterone. Intra-assay and inter-assay coefficients of 
variation were 7.9% and 21.2%, respectively. The sensitivity of 
the assay was 0.5 ng/100 ml dialysate which corresponds with a 
free plasma aldosterone concentration of 0.6 ng/100 ml. A negative 
blank value of 3.9 + 1.2(SD) pg was found for steroid-free plasma 
dialysates. The mean value of free aldosterone concentration in 
normal sheep (blood taken between 9-11 a.m.) was 1.8 + 1.2(SD) 
ng/100 ml, the mean free aldosterone fraction being 41.6 + 5.7(SD)% 
of total aldosterone concentration. It is concluded that the new 
method is a useful technique for the determination of the free 
aldosterone concentration in sheep which is independent of the 
binding level of the hormone. 
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Chapter 3 
TOTAL AND FREE PLASMA ALDOSTERONE IN SHEEP ACTIVELY 
IMMUNIZED WITH AN ALDOSTERONE-PROTEIN CONJUGATE 
INTRODUCTION 
Antisera raised against steroid-protein conjugates are important 
tools in endocrinological research. This concerns primarily the 
production of specific anti-steroid sera for use in radioimmuno-
assays. However, it has also been shown that such sera are capable 
to inhibit, oartly or completely, the biological activity of 
circulating steroid hormones. Lieberman et al. (1959) and Neri et 
al. (1964) demonstrated for instance, that the effects of estrone, 
testosterone, Cortisol or aldosterone could be abolished by the 
administration of the respective antibodies to test animals 
(passive immunization). Also in studies, in which animals were 
actively immunized with steroid-orotein conjugates, effects on 
the endocrine status of the intact host animal have been observed 
which indicate that the biological activity of the corresponding 
hormone was decreased. Nieschlag et al. (1973) immunized intact 
male rabbits with a testosterone-conjugate and demonstrated hyper-
plasia of the Leydig cells and testicular hypertrophy. Sundaram et 
al. (1973) reported that 2 out of 4 female Rhesus monkeys became 
anovulatory after immunization with an estradiol-protein conjugate. 
In another study of Nieschlag et al. (1974) it was demonstrated 
that immunization of male rabbits against corticosteroids is 
followed by adrenal hyperfunction and morphological signs of 
adrenal stimulation. In none of these studies however, the observed 
biological effects were related to the free, biological active 
hormone levels of these animals. 
Hillier et al. (1975) have shown that active immunization of 
intact male and female rats with testosterone-protein conjugates 
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leads to a decrease in the free circulating testosterone concen-
tration in both sexes. The concentration of free estradiol, how-
ever, appeared to be slightly elevated in both sexes after irununi-
zation with estradiol-protein conjugates. The contradiction between 
these findings were ascribed to the equilibrium dialysis technique 
used for the measurement of the free fraction. It appeared that 
this method is not sufficiently sensitive for detecting small 
changes in binding at levels greater than 99%. Criticism concerning 
the applicability of this equilibrium dialysis technique for the 
determination of the free hormone concentration in actively 
immunized animals has also been stated by Nieschlag et al. (1975), 
Thorneycroft et al. (1975) and Wickings and Nieschlag (1978). 
In order to define more precisely the exact nature of changes 
in circulating free hormone levels subsequent to active immunization 
of an intact host with a steroid-protein conjugate the present study 
was undertaken. The model chosen for investigation was immunization 
of intact sheep with aldosterone 21-monohemisuccinate-BSA. The free 
plasma aldosterone concentration has been determined by means of a 
combined equilibrium dialysis and radioimmuno procedure (Chapter 2). 
This method is, as distinct from the above mentioned technique, 
independent of the binding level of the hormone since it measures 
directly the free aldosterone present in the dialysate at 
equilibrium. 
Animals actively immunized with an aldosterone-protein conjugate 
showed a marked increase in total plasma aldosterone as demonstra-
ted by Gless et al. (1974), Nieschlag et al. (1974) and Haack et al. 
(1979) . To study the origin of the elevated total plasma aldosterone 
levels in actively immunized animals, immunization with radiolabelled 
aldosterone 21-monohemisuccinate-BSA and metabolic clearance deter-
minations of aldosterone in control and immunized sheep have been 
included in this Chapter. 
MATERIALS AND METHODS 
Immunizations 
Twenty Texel White ewes were used in this study. They were fed 
a normal diet with free access to food and water. Eighteen animals 
66 
were randomly divided into an immune group (n=9) and a control 
group (n=9). The immune group was immunized with aldosterone 21-
monohemisuccinate-BSA (Steraloids) which conjugate had between 15 
and 20 steroid molecules attached to each molecule of BSA. For 
primary immunization 2 mg of the conjugate was dissolved in 1 ml 
0.9% saline and emulsified in an equal volume of complete Freund's 
adjuvant (Calbiochem Behring Corp.). The suspension was injected 
subcutaneously at two sites into the back. They received further 
booster injections with 1 mg of the conjugate emulsified in the 
same adjuvant 2, 4, 6, 10, 14, 18, 20 and 23 weeks after primary 
immunization. Sham-immunization of the control group with an 
emulsion of 1 ml 0.9% saline in 1 ml complete Freund's adjuvant 
followed the same schedule as described for the immune group. Blood 
samples were collected at various times before the orimary immuni-
zation and thereafter (Fig. 3.6). Blood was drawn from the jugular 
vein between 9 and 11 a.m. using lithium héparine as anticoagulant. 
Plasma was separated by centrifugation at room temperature and 
stored at -20oC until assayed. 
Two sheep were immunized with ^Η-aldosterone 21-monohemisuccinate-
BSA. The radiolabelled conjugate was prepared according to the 
method described by Erlanger et al. (1957) with the use of d-(l, 2-
3H)-aldosterone (0.6 mCi/mmol). This labelled aldosterone was 
obtained by diluting d-(1, 2-^П)-aldosterone (New England Nuclear, 
50 Ci/mmol) with an appropriate amount of unlabelled d-aldosterone 
(Steraloids). The prepared conjugate had an average of 22 steroid 
molecules attacked to each molecule of BSA. The animals were given 
an initial subcutaneous injection of 2 mg (0.Θ yCi) of the conjugate 
dissolved in 1 ml 0.9% saline and emulsified in an equal volume of 
complete Freund's adjuvant. Booster injections of 1 mg (0.4 yCi) of 
the conjugate were applied at intervals of 2 weeks after primary 
immunization during a period of 14 weeks. Blood samples were 
collected before each booster injection and the antibody titre, 
total aldosterone and radioactivity concentration of the plasma 
were determined. Radioactivity was measured directly in plasma i.e. 
without any extraction or purification. 
Metabolic clearance determination 
The metabolic clearance rate (MCR) in 4 control and 4 immunized 
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sheep was determined, at 37 weeks after primary iiranunization, 
according to the single-injection technique of Tait et al. (1961). 
d-(l, 2-3H)-Aldosterone (New England Nuclear, 50 Ci/mmol) in 
ethanol was dissolved in 5% glucose and injected intravenously into 
the jugular vein. The controls received 10 or 20 uCi and the 
immunized animals 5 or 10 uCi -^H-aldosterone aoOroximately. Blood 
samples were taken from an indwelling cannula in the jugular vein 
at 7.5 min intervals over the first 30 min , and then at various 
times over the next 90 and 150 min period for control and 
immunized animals, respectively. Plasma was separated by centrifu-
gation at room temperature and stored at -20oC awaiting analysis. 
The Η-aldosterone concentration in plasma was determined after 
paper chromatography of dichloromethane extracts in the Bush B5 
system. Corrections for procedural lossed were based on the recovery 
of 550 dpm of d-(4-•l4C)-aldosterone (New England Nuclear, 50 Ci/ 
mmol). One milliliter plasma of immunized sheep was incubated with 
^C-aldosterone for 18h at 40c. Before extraction the antibody-
aldosterone complex was dissociated by lowering the plasma pH using 
200 ul 5N HCl. Plasma of control sheep (5-13 ml) was incubated for 
30 min at room temperature with C-aldosterone and extracted 
without prior treatment. After chromatography the paper strips 
were scanned for radioactivity on a TMC Model 880 Autoscanner and 
the appropriate area was eluted in 1 ml ethylene glycol/water 
(0.2%). Eight hundred microliter were added to 10 ml of scintilla-
3 14 tion fluid (Aqua Luma, Baker) and counted for H and С in a 
liquid scintillator (Searle Isocap 300) for 100 min together with 
appropriate background and standard vials. Counting efficiency was 
50.7% for 1 4C and 41.0% for 3H with a feed-through of 15.5% of 1 4С 
into the tritium channel. The initial H content of the plasma, 
present specifically as aldosterone, was calculated after correc­
ting for losses during the isolation procedure. The mean recovery 
of the 1 C-aldosterone was 73.5 + 7.7(SD)% (n=30) for control and 
77.1 + 6.5(SD)% (n=36) for immunized animals. 
The plasma ^H-aldosterone levels were expressed as the percentage 
of the injected dose per liter plasma and plotted on a semilog 
scale against time after injection. For each individual animal half-
life of aldosterone and the MCR and production rate (PR) were cal­
culated according to Tait et al. (1961). 
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Antibody characterization 
The antibodies raised against aldosterone were characterized 
using the radioimmunoassay technique described in Chapter 1. Plasma 
samples were serially diluted and incubated with 7500 dpm (22 pg) 
of ^H-aldosterone for 18h at 40C. Free and antibody-bound tracer 
were separated by dextran-coated charcoal. The antibody titre was 
taken as the reciprocal of the plasma dilution at which 50% of the 
added 3H-aldosterone was bound. A significant titre was defined in 
this study as anything greater than 1:100 dilution. Antibody 
specificity was determined by testing the ability of steroid hor­
mones other than aldosterone to displace the antibody-bound ^н-
aldosterone. The amount of these hormones displacing 50% of the 
Зн-aldosterone was used to calculate the percentage cross reacting 
according to Abraham (1969). Binding affinity and binding capacity 
were calculated from plots constructed from dose-response curves 
according to Scatchard (1949). Specificity and binding characteris­
tics were assessed at plasma dilutions that were determined to be 
the antibody titre. 
Total plasma aldosterone 
Plasma levels to total aldosterone were determined by a radio­
immunoassay method previously described (Chapter 1). Measurements 
were performed after extraction and paper chromatography, in the 
Bush B5 system, of 2 ml plasma using an antiserum raised against 
aldosterone 21-monohemisuccinate-BSA (S83). Antibody-bound and 
free fractions were separated by dextran-coated charcoal. The method 
was slightly modified for plasma taken from immunized animals 
which had significant antibody titres. Prior to extraction the 
recovery tracer was incubated with 0.1 ml of plasma at 40C for 18h 
to allow full equilibration with the endogenous aldosterone pool. 
Dissociation of the antibody-aldosterone complex was obtained by 
lowering the plasma pH using 20 μΐ 5N HCl; this mixture was left 
for 5 min. before extraction with dichloromethane. After chromato­
graphy appropriate dilutions of the eluate were made with ethylene 
glycol/water 0.2% and dunlicate aliquots of 300 yl were taken for 
assay. 
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Free plasma aldosterone 
The free aldosterone concentration in plasma was estimated by 
a combined equilibrium dialysis and radioimmunoassay procedure as 
described in Chapter 3. After equilibrium dialysis of a 1 ml plasma 
sample against 1 ml 0.15M phosphate buffer (pH 7.4) for I8h at 370C, 
the concentration of aldosterone in the buffer solution was measured 
by a direct radioimmunoassay using an antiserum raised against 
aldosterone 18, 21-diacetate-3-carboxymethyloxime-BSA (S85). The 
free aldosterone concentration in plasma was calculated from this 
concentration of dialysable aldosterone and the total plasma aldos­
terone concentration. 
The free aldosterone fraction was expressed as percentage 
of the total plasma aldosterone concentration. At 49 weeks 
after primary immunization the concentration free plasma aldos­
terone in control sheep was below the limit of detection 
(Fig. 3.6). The fraction free aldosterone in these plasmas was 
determined by the equilibrium dialysis method described in Chapter 
2 as the tracer method. 
The specificity of this method for determining free aldosterone 
in plasma of aldosterone-immunized sheep was examined by immuno-
chromatographic analysis of a dialysate of pooled plasma. The 
immunogram was prepared according to the procedure described in 
Chapter 2. The distribution on the chromatogram and the amount 
of cross reacting steroids present in the dialysate of imnunized 
animals showed no difference when compared with a control dialysate 
of pooled plasma (Fig. 3.1). It is apparent from this observation 
that the free aldosterone in the dialysate of control and immunized 
sheep after equilibrium dialysis was radioimmunoassayed with the 
same specificity. 
Statistical analysis 
The data were expressed as the group mean and the standard error 
of the mean (SEM). The statistical significance of differences 
between the mean values of immunized and control sheep were calcu­
lated using Student's t-test and Wilcoxon's rank sum test for non-
paired data. The difference was considered to be significant when 
the P-value was less than 0.05. Correlation tests were performed by 
linear regression analysis at a significance level of ρ <0.05. 
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Fig. 3.1 Immunochroraatographic analysis of plasma dialysate of 
control and aldosterone immunized sheep after equilibrium dialysis 
employing antiserum S85. After the addition of ^Η-aldosterone the 
dialysate was extracted and chromatographed in the Bush B5 paper-
system. The chromatogram was divided into 1 cm strips which were, 
after elution, assayed for immunoactivlty ( ) and radioactivity 
( ). 
RESULTS 
Antibody characterization 
The development of antibody titres in nine sheep immunized 
aldosterone 21-monohemisuccinate-BSA is shown in Fig. 3.2. The 
time course of the titres was followed for a period of 55 weeks. 
All animals immunized were found to have circulating antibodies; 
one animal died during the observed period. The first significant 
antibody activity (titres >1:100) could be detected 3 weeks after 
primary immunization. Although a high response was observed in all 
but one animal, there was considerable variability in the maximum 
titres attained; the values of the maximal titres ranged between 
38,400 and 615,000. In the remaining animal the titre reached not 
more than 2,600. The patterns of response of the animals were 
simular during the observation period: an early and steep increase 
in antibody titre which showed plateauing thereafter. By week 30 
the titres generally decreased gradually but remained elevated 
for the duration of the experiment or until death. The titres at 
the end of the observed period ranged from 10,5000 to 46,5000; 
sheep 98 had an end titre of 350. Affinity constants and binding 
antibody titre 1 
Fig. 3.2 The development of antibody titres in nine sheep following 
.active immunization with aldosterone 21-monohemisuccinate-BSA. 
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capacities of the antibodies, determined in the plasma with the 
maximal titre were in the order of 109 litres/mol and IO - 5 mol/ 
litres, respectively (Table 3.1); sheep 98 had a binding capacity 
in the order of 10 mol/litres. However, a considerable variation 
m binding affinity was observed between the individual animals. A 
significant correlation exists between the affinity constants of 
the antibodies and hight of the maximal titre (r=0.84, ρ <0.01, 
n=9) . 
Three sheep, which developed high antibody titres, were studied 
in detail to obtain information on antibody specificity and binding 
characteristics related to the duration of immunization. Antibodies 
were examined at the maximal titre and at several points before 
and thereafter. The results of these experiments are listed in 
Table 3.2. Considerable variation among animals in cross reactivity 
was observed. There was also a large variation in cross reactivity 
between the five steroids tested, in all three animals. Except 
for Cortisol and corticosterone in sheep 78, the cross reactivity 
of the antibodies tended to decrease as long as the animals were 
boosted. Thereafter cross reactivity remained unchanged, or fell 
slightly. Binding affinity and binding capacity showed very slight 
changes in the course of the observed period. The lowest binding 
affinity of the antibodies (in sheep 94) was associated with the 
lowest specificity. 
Table 3.1 Affinity constants (K0) and binding capacities (Ab0) of 
aldosterone binding antibodies in the plasma with the maximal titre 
in nine sheep actively immunized with aldosterone 21-monohemi-
succinate-BSA. 
Sheep no. 
03 
76 
78 
80 
94 
96 
97 
98 
100 
Antibody 
titre 
465,000 
72,000 
615,000 
210,000 
420,000 
171,000 
38,500 
2,600 
330,000 
K
o
 A bq 
(1/mol) (mol/l 
27.5xl09 2.8xl0"5 
9.8xl09 l.lxlO-5 
10.4xl09 З.бхЮ - 5 
13.8x109 2.3xl0"5 
7.2xl09 9.2xl0-5 
6.2xl09 3.4x10-5 
1.8xl09 1.7x10-5 
1.2xl09 1.2ХІ0"6 
22.6ХІ09 З.бхЮ - 5 
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*" Table 3.2 Titre, affinity constants (K0), binding capacities (Ab0) and specificity of aldosterone 
binding antibodies at different times after primary immunization in three sheep actively immunized 
with aldosterone 21-monohemlsuccinate-BSA. Specificity is determined by measuring the percentage 
cross reaction with Cortisol (F), corticosterone (В), 18-hydroxycorticosterone (18-OH-B), 11- deoxy­
corticosterone (DOC) and 18-hydroxydeoxycorticosterone (18-0H-D0C). All steroids were obtained from 
Steraloids 
Sheep Weeks after primary Antibody K 0 Abg Percentage cross reactivity 
no. immunization titre (1/mol) (mol/l) F В 18-OH-B DOC 18-0H-D0C 
16 90,000 15.9ХІ09 l.OxlO"5 
26 615,000 10.4xl09 8.6xl0"5 
78 34 168,000 10.8ХІ09 2.7xl0"5 
45 57,000 11.9xl09 Ο.βχΙΟ-5 
55 46,500 ІЗ.ЗхЮ 9 О.бхЮ - 5 
11 96,000 lO.OxlO9 Ο.βχΙΟ-5 
22 72,000 9.6ХІ09 l.OxlO-5 
80 26 210,000 ІЗ.ВхІО9 2.3xl0"5 
32 84,000 15.7ХІ09 Ο.βχΙΟ-5 
45 27,000 12.0ХІ09 O.lxlO-5 
14 31,500 3.9xl09 Ο.βχΙΟ"5 
22 153,000 5.8xl09 5.2xl0~5 
94 26 420,000 7.2xl09 9.2xl0~5 
32 114,000 4.7ХІ09 4.0xl0-5 
45 16,800 4.3xl09 Ο.θχΙΟ-5 
0 . 0 5 9 
0 . 5 3 1 
0 . 3 9 1 
0 . 8 5 5 
0 . 7 7 4 
0 . 0 9 8 
0 . 0 6 6 
0 . 1 2 3 
0 . 0 9 8 
0 . 0 6 3 
0 . 5 0 5 
0 . 1 9 0 
0 . 1 7 1 
0 . 1 7 6 
0 . 2 0 4 
0 . 5 5 1 
2 . 3 8 6 
1 .923 
4 . 1 4 2 
3 . 6 7 4 
1.64 
0 . 4 6 2 
0 . 2 5 8 
0 . 2 0 7 
0 . 1 5 4 
1 9 . 1 
3 . 9 1 
3 . 1 1 
2 . 8 1 
3 . 1 7 
0 . 2 9 5 
0 . 3 5 4 
0 . 3 1 3 
0 . 3 2 6 
0 . 3 3 4 
0 . 5 2 5 
0 . 1 1 8 
0 . 0 6 3 
0 . 0 4 6 
0 . 0 3 6 
4 . 1 6 
0 . 9 5 6 
0 . 7 5 9 
0 . 9 1 2 
1.02 
0 . 6 2 8 
0 . 2 5 4 
0 . 3 8 5 
0 . 1 1 2 
0 . 1 2 0 
6 . 6 0 
1 .32 
1.23 
0 . 9 2 1 
0 . 9 8 0 
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4 1 . 3 
4 6 . 3 
1 8 . 8 
1 5 . 9 
0 . 2 8 1 
0 . 1 0 1 
0 . 1 8 3 
0 . 0 3 9 
0 . 0 3 3 
3 . 6 4 
0 . 8 0 4 
0 . 6 1 3 
0 . 5 2 3 
0 . 3 7 0 
1 7 . 0 
6 . 9 4 
6 . 3 8 
6 . 9 1 
5 . 4 6 
Total plasma aldosterone 
The levels of total aldosterone in plasma from the nine immunized 
sheep are shown in Fig. 3.3. Total plasma aldosterone increased 
sharply after immunization and remained elevated throughout the 
observed period. The total plasma aldosterone concentrations were 
significantly increased at 2 weeks after primary iitununization, 
before antibody titres could be detected. The mean concentration 
was 58.4 + 23.0 ng/100 ml (+ SEM) compared to 12.0 + 1.6 ng/ 100 ml 
in the nine control animals (p < 0.01). The plasma concentration 
continued to rise until a plateau was reached and then started to 
decline gradually. Maximal values observed ranged from 8,000 to 
292,000 ng/100 ml which was 1,700 to 55,000-fold higher than the 
total plasma aldosterone (ng/100 ml) , 
1 0 6
- | 1 2 3 4 5 6 7 8 _ _ „ . _ 
st nd rd in th th th th Booster 
1 i i i 1 i i 1 
Fig. 3.3 Total plasma aldosterone levels in nine sheep following active 
immunization with aldosterone 21-monohemisuccinate-BSA. The shaded area 
represents the mean +SEM total plasma aldosterone concentration in 
nine control sheep. 
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corresponding control values. At the end of the observed period the 
mean plasma concentration was 17,700 + 4,300 ng/100 ml (+SEM) 
compared to 4.0 + 1.0 ng/100 ml in the control animals. Total plasma 
aldosterone levels were significantly correlated with the antibody 
titres as shown in Fig. 3.4. Correlation coefficients of the indi­
vidual animals ranged from 0.74 (n=20) to 0.98 (n=21) with a mean 
value of 0.90 + 0.02 (+SEM, ρ < 0.001, n=9). 
total plasma aldosterone (ng/100 ml) · 
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Fig. 3.4 Relat ionship between t o t a l plasma aldosterone concentrat ion 
and antibody t i t r e in nine sheep ac t ive ly immunized with aldosterone 
21-monohemisuccinate-BSA (n=174). Regression l i n e represents the mean 
l i n e a r regress ion l i n e of the nine animals. 
Free plasma a l d o s t e r o n e 
The f r e e a l d o s t e r o n e f r a c t i o n i n plasma from immunized sheep i s 
shown in F i g . 3 . 5 . A s i g n i f i c a n t d e c r e a s e i n t h e f r e e f r a c t i o n i s 
observed 2 weeks a f t e r primary immunization (p < 0 . 0 5 ) . The mean 
f r e e f r a c t i o n was 23.7 + 6.2% (+SEM) compared t o 42.0 + 2.1% in 
t h e n i n e c o n t r o l a n i m a l s . The f r e e f r a c t i o n c o n t i n u e d t o d e c r e a s e 
u n t i l minimum v a l u e s were reached r a n g i n g from 0.080 t o 0.00082%. 
76 
Thereafter the free fraction began to rise and at the end of the 
observed period the mean value was 0.072 + 0.041% (+SEM). In the 
control group no variation in the free fraction appeared in the 
same period; the mean values remained between 33.4 and 45.7%. The 
free aldosterone fraction in the plasma of immunized animals was 
negatively correlated with the antibody titre; correlation 
coefficients of the individual animals ranged from-0.82 (n=13) to 
-0.98 (n=14) with a mean value of -0.92 + 0.02 (+SEM, ρ < 0.001, 
n=9) . 
fraction free aldosterone C/o) 
Ю0 
10 
0.1 
0.01 
0001 
40 50 60 
weeks after primary immunization 
F i g . 3 .5 The f r e e a l d o s t e r o n e f r a c t i o n i n t h e p lasma of n i n e s h e e p 
a c t i v e l y immunized w i t h a l d o s t e r o n e 21-monohemisuccinate-BSA. The 
shaded a r e a r e p r e s e n t s t h e mean +SEM f r e e a l d o s t e r o n e f r a c t i o n i n 
t h e p lasma of n i n e c o n t r o l s h e e p . 
The free aldosterone concentration in plasma from immunized and 
control sheep was determined a t d i f ferent times before and during 
immunization u n t i l week 55. Mean free plasma aldosterone levels of 
the individual animals before the experimental period (n=6) ranged 
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from 0.9 to 3.5 ng/100 ml and from 1.0 to 3.0 ng/100 ml for 
Immunized and control sheep, respectively. During the experimental 
period, from week 3, the mean free plasma aldosterone concentration 
(n=16) of the immunized sheep ranged from 3.5 to 5.4 ng/100 ml and 
of the controls from 2.0 to 3.5 ng/100 ml. Mean free aldosterone 
levels before immunization of the individual animals of the immune 
and control group were not significantly different (p > 0.05). 
During the experimental period, however, the mean free aldosterone 
concentrations of the immunized sheeo were significantly higher 
(p < 0.001). As seen in Fig. 3.6, there was a rise in the free 
aldosterone concentration in both groups 2 weeks after primary 
immunization. Peak levels were reached 3 weeks after primary 
immunization with mean values of 7.5 + 1.0 ng/100 ml (+SEM) and 
5.8 + 0.8 ng/100 ml for the immune and control group, respectively. 
Free aldosterone concentration then fell gradually to lower values 
in both groups. In the control group, the free aldosterone concen­
tration fell to values within the range of the pre-immunization 
level. In the immune group, however, free plasma aldosterone 
remained above the pre-immunization level throughout the observed 
period. The free aldosterone concentration in the immune group was 
significantly higher at week 6 (p < 0.001), 8 (p < 0.01), 14 
(p < 0.001), 22 (p < 0.001), 30 (p < 0.01),34 (p < 0.005), 37 
(p < 0.05),45 (p < 0.005), 49 (p < 0.001), 51 (p < 0.001) and 
55 (p < 0.001) after primary immunization when compared with 
values at the same times in the control group. Mean free aldosterone 
levels at any of the six points in the immune and control group in 
the period before immunization were not significantly different. 
The mean free plasma aldosterone concentrations of immune and 
control group were significantly correlated (r=0.84, ρ < 0.001, 
n=16) during the experimental period from week 3 on, when aldoste-
rone-binding antibodies are present in all immunized animals as 
indicated by a decreased free aldosterone fraction (Fig. 3.5). 
Free plasma aldosterone levels in the immunized sheep were 
significantly correlated with the total plasma aldosterone concen­
trations from week 11 on, when antibody titres had reached a 
plateau and decreased gradually thereafter (Fig. 3.2). Correlation 
coefficients of the individual animals ranged from -0.06 (n=l0) 
to 0.75 (n=ll) with a mean value of 0.40 + 0.08 (+SEM, ρ < 0.005, 
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Fig. 3.6 Free plasma aldosterone concentrat ion in nine sheep a c t i v e l y 
immunized with aldosterone 21-monohemisuccinate-BSA ( ) compared 
with t h a t in nine control sheep ( ) before and during the 
experimental per iod. Values represent means +SEM. S t a t i s t i c a l l y s i g n i f i ­
cant di f ferences are indicated by ( · ) . The free plasma aldosterone 
concentrat ion in the contro l sheep a t week 49 was below the l i m i t of 
d e t e c t i o n . 
Immunization with rad io labe l led conjugate 
To determine whether the e levated t o t a l a ldosterone l e v e l s 
found in the immunized sheep are due t o a ldosterone r e l e a s e from 
the a ldosterone-prote in conjugate, two sheep were immunized with 
•^H-aldosterone 21-monohemisuccinate-BSA. Total a ldosterone con­
centrat ions in the two animals showed a s i g n i f i c a n t e l e v a t i o n a t 
4 weeks a f ter primary immunization and remained above normal phy­
s i o l o g i c l e v e l s during the experimental period (Table 3 . 3 ) . Radio­
a c t i v i t y was d e t e c t a b l e in the c i r c u l a t i o n of both sheep at 2 weeks 
a f ter primary immunization. The aldosterone content which could be 
derived from the amount of plasma r a d i o a c t i v i t y far exceeded the 
t o t a l plasma aldosterone values which were not changed (S50) or 
s l i g h t l y increased (S49) at that time. This i n d i c a t e s that the 
H-aldosterone-protein conjugate in the c i r c u l a t i o n a t week 2 was 
s t i l l i n t a c t and no s i g n i f i c a n t amount of a ldosterone was re leased 
from degraded conjugate. Fourteen weeks a f t e r primary immunization 
the concentrat ions of t o t a l a ldosterone and r a d i o a c t i v i t y in the 
plasma of both animals reached maximal v a l u e s . The r a d i o a c t i v i t y 
found in the c i r c u l a t i o n of both animals at that time represented 
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1.0% of t h e t o t a l amount of r a d i o a c t i v i t y a d m i n i s t e r e d d u r i n g t h e 
e n t i r e immunization p e r i o d . Assuming t h a t a l l of t h e plasma 
r a d i o a c t i v i t y was p r e s e n t as a l d o s t e r o n e , t h e immunizing conjugate 
could account for 1.0 and 11.7% of t h e t o t a l c i r c u l a t i n g a l d o s t e ­
rone in sheep 49 and 50, r e s p e c t i v e l y . 
Table 3.3 Antibody t i t r e , plasma concentrat ion of t o t a l a ldosterone 
and r a d i o a c t i v i t y , and the aldosterone content of the plasma r a d i o ­
a c t i v i t y a t d i f f e r e n t times a f t e r primary immunization in two sheep 
a c t i v e l y immunized with Η-aldosterone 21-monohemisuccinate-BSA. 
no. 
Sheep Weeks after Antibody Total plasma Plasma Aldosterone 
primary titre aldosterone radio- content plasma 
immunization (ng/100 ml) activity radioactivity 
(dpm/1) (ng/100 ml) 
49 
50 
0 
2 
4 
6 
8 
10 
12 
14 
0 
2 
4 
6 
8 
10 
12 
14 
0 
102 
900 
5,400 
7,800 
15,300 
25,500 
0 
0 
330 
960 
1,350 
2,850 
2,100 
2. 
5. 
615 
4,149 
15,766 
22,008 
29,734 
29,186 
5. 
4. 
192 
556 
998 
644 
2,123 
2,744 
2 
5 
1 
6 
4,800 
7,600 
8,400 
4,500 
4,000 
3,000 
12,200 
4,000 
5,400 
4,200 
2,100 
1,300 
500 
12,800 
120 
190 
210 
113 
100 
75 
305 
100 
135 
105 
53 
33 
13 
320 
Metabolic clearance determination 
The plasma ^H-aldosterone levels (as percentage of the injected 
dose per liter of plasma) in control and immunized sheep after 
injection of radioactive aldosterone are shown in Fig. 3.7. Immedia­
tely after injection the mean plasma -^n-aldosterone concentration 
was 5.9 + 2.6 (+SEM)% in the control and 51.3 + 4.6% in the 
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immunized sheep. While the ^H-aldosterone then disappeared rapidly 
from plasma in controls until about 30 min after injection, the 
immunized animals retained the injected radioactive aldosterone 
much longer. The mean plasma 3H-aldosterone concentration 30 min 
after injection was 0.48 + 0.15% (+SEM) and 39.5 + 2.7% in control 
and immunized sheep, respectively. Thereafter, the disappearance 
rate became much slower in both groups and a straight line was 
obtained up to 120 min , for control, and 160 min after injection 
for immunized animals. At that time, the mean plasma 3H-aldosterone 
concentration was 0.043 + 0.013% (+SEM) and 29.4 + 4.0% in control 
and immunized sheep, respectively. 
% injected 3H-aldosterone/l plasma • 
100 
10 
01 
ooi 
immunized 
— » - -• 
— ι 1 1 1 1 1— 
3 0 6 0 9 0 120 150 1Θ0 
minutes after injection 
Fig. 3.7 Plasma disappearance curves of 3 H-aldosterone in control 
and aldosterone-immunized sheep p lot ted on a semilog scale showing 
the percentage of in jected Зн-aldosterone per l i t e r plasma against 
t ime. 
From t h e plasma d i s a p p e a r a n c e curves h a l f - l i f e , MCR and PR of 
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aldosterone in control and immunized sheep were calculated. As 
shown in Table 3.4, the MCR of aldosterone in the immunized animals 
had decreased by a factor of 530 over that in the controls . Within 
the immunized group the lower MCR was associated with a higher 
antibody t i t r e . The calculated PR of aldosterone in the immunized 
sheep was 9 times higher than in the controls . 
Table 3.4 Half-life Crt), metabolic clearance rate (MCR) and 
production rate (PR) of aldosterone in control and aldosterone-
immunized sheep. All differences between means of corresponding 
parameters were statistically significant. 
T^ MCR PR Total plasma Antibody 
(h) (1/day) (mg/day) aldosterone t i t r e 
(ng/100 ml) 
8 
8 
3 
3 
6 
5 
111,000 
132,000 
42,000 
52,500 
84,375 
21,964 
DISCUSSION 
All nine sheep actively immunized with aldosterone 21-monohemi-
succinate-BSA produced antibodies with an increased capacity to 
bind t r i t i a t e d aldosterone when tested in a dextran-coated charcoal 
radioimmunoassay. This antibody formation resulted in a tremendous 
increase in the amount of to t a l plasma aldosterone, reaching con-
centrat ions, which were 1^700 to 55,000 times higher than in the 
controls (Fig. 3.3) . A similar evelation of plasma aldosterone 
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79 
82 
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SEM 
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80 
94 
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SEM 
0.42 
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0.56 
0.54 
0.50 
0.03 
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0.3 
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2681 
4333 
3984 
3014 
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4. 
7. 
6. 
5. 
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1 
.6 
.7 
,7 
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2.58 
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0.28 
54, 
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25, 
37 
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9. 
5. 
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7. 
1. 
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,552 
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levels was reported by Gless et al. (1974), Nieschlag et al. (1974) 
and Haack et al. (1979) in rabbits and sheep actively immunized 
against aldosterone. Animals actively immunized against cortico-
steroids other than aldosterone, testosterone and estradiol showed 
also a considerable increase in the plasma concentration of the 
corresponding steroid hormones (Nieschlag et al., 1973, 1974; 
Sundaram et al., 1973; Gless et al., 1974; Hillier et al., 1975; 
Schwartz et al., 1975; Thorneycroft et al., 1975, Wickings and 
Nieschlag, 1978) . A possible cause for this increase in plasma 
concentration of the various steroid hormones could be the release 
of hormone from the immunizing conjugate as stated by O'Neill and 
Robb (1976) . In the present study a significant contribution from 
the aldosterone-protein conjugate to the total plasma aldosterone 
levels must be considered highly unlikely for the following two 
reasons. First, the amount of conjugate administered during the 
whole immunization procedure was 10 mg, an amount which corresponds 
maximally with 2.6 \imol of aldosterone. From the total plasma 
aldosterone concentrations measured at 22 weeks after primary 
immunization it can be inferred that the body pool of aldosterone, 
assuming it is confined to a plasma compartment of 5 1, ranged 
from 0.35 to 40 ymol. Only in two cases with estimated pool sizes 
of 3.2 and 0.35 ymol the conjugate could account for most or all 
the aldosterone. In the other seven cases the estimated pool 
sizes varied between 6.4 and 40 umol which means that the larger 
part of circulating aldosterone must have been of endogenous origin. 
Secondly, in a separate experiment in which radiolabelled conjugate 
was injected, it was found that only 1% of the administered dose 
was present in the circulation at the end of the immunization period. 
Thus, the increase of total plasma aldosterone levels must be 
considered to originate primarily from an increase in PR or a 
decrease in disposal rate. 
Fluctuations in production and disposal rates may occur indepen-
dently, but may also occur simultaneously to produce elevated 
plasma levels. Delayed disappearance rates of the corresponding 
radiolabelled hormone has been presented in this study (Fig. 3.7) 
and by Sundaram et al. (1973) after immunization against estradiol, 
Gless et al. (1974) after immunization against corticosteroids, 
Schwartz et al. (1975) after immunization against estradiol and 
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progesterone and Wickings et al. (1976) after immunization against 
testosterone. A prolonged half-life of aldosterone and a decreased 
MCR were found (Table 3.4) in the aldosterone-immunized sheep. The 
cause for a decreased MCR is considered to be a decrease of the 
proportion of the aldosterone that is available for degradation. 
Measurements of total and free aldosterone clearly demonstrated 
that the increase in plasma aldosterone is almost exclusively an 
increase of bound hormone. From the fact that total plasma aldoste-
rone concentration and antibody titre were significantly correlated 
(Fig. 3.4) it is concluded that antibody binding prevents the 
removal of aldosterone from the circulation by the usual metabolic 
processes. It is generally accepted that steroid hormones can enter 
tissue cells only in their free form. However, this does not mean 
that protein bound hormones is completely unavailable for degra-
dation. Experiments by Pardridge et al. (1979) indicate that 
aldosterone is available to liver cells both in its free form and 
when bound to its normal plasma binding proteins (corticosteroid 
binding globulin and albumin). The elevation of free aldosterone 
levels in the immunized group (Fig. 3.6) is consistent with the 
finding of an elevated PR. However, the PR is more strongly 
elevated than the free aldosterone levels, indicating the possibi-
lity that also a proportion of antibody-bound aldosterone is availa-
ble for degradation. 
In the initial phase of immunization a decreased fractional 
disposal rate with total aldosterone levels within the normal range, 
will result in a decreased absolute disposal also. With secretion 
by the adrenals at a normal level the balance between production 
and disposal is disturbed, which results in an increase of the 
plasma level of aldosterone. Plasma levels will rise until a new 
steady state is reached which is characterized by a decreased 
fractional disposal rate, an increased plasma level and a normal 
absolute disposal rate, which is equal to the PR of the hormone.This 
steady state will be reached when the amount of hormone available for 
degradation has reached its normal value again. Thus, an explanation 
for the elevated total plasma aldosterone levels can be given which 
does not involve any assumption of an increased aldosterone PR. The 
metabolic clearance determinations showed indeed a strongly 
decreased MCR (Table 3.4). However, the rise in total plasma aldos-
84 
terone concentration was such that absolute disposal rates were 
still elevated. In steady state the aldosterone PR is elevated so 
that the rise in total plasma aldosterone cannot be ascribed solely 
to decreased fractional disposal. The increased PR, found in the 
aldosterone-immunized sheep, was in agreement with the observation 
of Wickings et al. (1976) in rabbits immunized with a testosterone-
protein conjugate. It was shown that the PR of testosterone in these 
animals was increased. Evidence for an increased PR in actively 
immunized animals was also provided by morphological findings which 
indicate a hyperfunction of the corresponding endocrine glands. 
Nieschlag et al. (1973, 1974), Hillier et al. (1975) and Wickings 
and Nieschlag (1978) demonstrated that immunization of animals 
against testosterone, corticosteroids or estradiol resulted in 
hypertrophy and nuclear hyperplasia of the corresponding glands. 
Whereas there is general agreement on the rise of plasma hormone 
levels in animals actively immunized with the corresponding steroid-
protein conjugate, literature data reported on free hormone levels 
are scarce and conflicting. Elevated levels of free plasma testo-
sterone in rabbits immunized with a testosterone-protein conjugate 
can be calculated from the data given by Nieschlag et al. (1973, 
1974, 1975) and Wickings et al. (1976). However, Hillier et al. 
(1975) reported decreased levels of free testosterone in rats 
immunized against testosterone. The concentration of free estradiol 
appeared to be elevated in rats immunized with an estradiol-protein 
conjugate as reported in the same study (Hillier et al., 1975). 
Strongly elevated plasma levels of free aldosterone in sheep and 
rabbits immunized against aldosterone have been published by Haack 
et al. (1979). In all these studies a tracer equilibrium dialysis 
technique was used for the determination of the free hormone 
concentration. This procedure lacks precision and accuracy, especial-
ly when binding levels exceed 99% as stated by Hillier et al. (1975), 
Nieschlag et al. (1975), Thorneycroft et al. (1975) and Wickings 
and Nieschlag (1978). As already discussed in Chapter 2 this 
technique requires an unrealistic high degree of purity of the tracer 
at these very high binding levels. In the present study the free 
plasma aldosterone concentration has been determined by a combined 
technique of equilibrium dialysis and radioimmunoassay. By 
measuring aldosterone directly in the equilibrium dialysate by 
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radioimmunoassay this method is independent of the binding level 
of the hormone. Thus, it can be assumed that the free aldosterone 
levels in the plasma of aldosterone-immunized sheep found in this 
study reflected the actual concentrations. 
From the present results it appears that the free fraction aldos-
terone in the control sheep remained unchanged during the experimen-
tal period (Fig. 3.5). As a results of the constancy of the free 
fraction, total and free aldosterone levels in the control animals 
essentially move parallel. The concentration of free aldosterone 
depends on the concentration of total aldosterone and the concentra-
tion of all plasma binding sites. A clearly defined relation 
between free and total plasma aldosterone exists only when the level 
of these binding sites remains stable. In the plasma of the immunized 
sheep new classes of binding sites appear which rise rapid-
ly in concentration in the first phase of immunization (Fig. 3.2). In 
this situation it cannot be expected tha* changes in total plasma aldos-
terone are reflected by changes in the free plasma concentration. After 
this period, when antibody titres had reached a plateau, free plasma 
aldosterone levels were significantly correlated with the total 
plasma aldosterone concentration. Also there was a significant 
correlation between the mean free plasma aldosterone concentrations 
of immune and control group during the experimental period. From 
these observations it may be concluded that free plasma aldosterone 
in the immunized sheep, allthough at a higher level, is regulated 
by the same mechanism as in the control animals. Elevated levels 
of free aldosterone, however, are not consistent with an increased 
PR when it is assumed that free aldosterone participate in a 
negative feedback control of aldosterone production. This contra-
diction does not exist when the negative feedback action of aldoste-
rone was overuled by a stimulatory effect on the aldosterone 
production. The proposed mechanism will be further discussed in 
the next chapter in which observations on the electrolyte levels 
are considered. 
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SUMMARY 
Nine ewes were actively immunized with aldosterone 21-monohemi-
succinate-BSA to determine the effect of this procedure on the 
circulating free aldosterone levels. The animals were studied for 
a period exceeding one year, together with nine sham-immunized 
ewes as controls. Total and free aldosterone, the antibody titre 
and the free aldosterone fraction in plasmas collected at various 
times after primary immunization were measured. The production 
of antibodies to aldosterone was always accompanied by a marked 
increase in total plasma aldosterone levels, reaching concentra­
tions, which were 1,700 to 55,000 times higher than in the controls. 
Total plasma aldosterone was significantly correlated with the 
antibody titre. The mean value of the correlation coefficients of 
the individual animals was 0.90 + 0.02 (+SEM, ρ <0.001). Immuniza­
tion against aldosterone was also accompanied by a decrease in the 
free aldosterone fraction reaching minimal values ranging from 
0.080 to 0.00082%. In the control group the mean free fraction 
remained between 33.4 and 45.7%. The decrease in the free fraction, 
however, was not proportional to the enormous increase in total 
aldosterone concentration, so the free plasma aldosterone concen­
tration appeared to be slightly elevated over the controls. The 
mean free plasma aldosterone concentrations of immune and control 
group were significantly correlated during the experimental period 
(r=0.84, ρ <0.001). 
Furthermore, to identify the cause of the increased total plasma 
aldosterone levels, immunization with radiolabelled conjugate and 
metabolic clearance determinations were performed. In two sheep 
actively immunized with ^Η-aldosterone 21-monohemisuccinate-BSA, 
significantly elevated total plasma aldosterone levels were found 
14 weeks after primary immunization. Only 1% of the dose administe­
red during the immunization period was found in the plasma of both 
animals. This indicates that the increase in total plasma aldoste­
rone originates from endogenously produced hormone. The half-life 
of aldosterone, the metabolic clearance rate (MCR) and the 
production rate (PR) were determined in four control and four 
immunized sheep after a single injection of ^Η-aldosterone. In the 
immunized group the half-life of aldosterone was significantly 
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prolonged, the MCR had dropped by a factor 530 over that in the 
controls (5.7 + 0.7 1/day (+SEM) compared to 3,014 + 743 1/day) 
and the PR showed an increase 9 times that of the control group 
(1.97 + 0.28 mg/day (+SEM) compared to 0.22 + 0.07 mg/day). Thus, 
the elevated total plasma aldosterone levels observed in the 
immunized sheep are the result of a decreased MCR in combination 
with an increased PR. An increased PR, however, is in contradiction 
with the elevated free plasma aldosterone concentration, assuming 
that the free levels participate in a negative feedback control of 
aldosterone production. It is suggested that the negative feedback 
action of aldosterone in the immunized sheep might be overuled 
by a stimulatory effect on the aldosterone production. 
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Chapter 4 
PLASMA ELECTROLYTES AND ALDOSTERONE-POTASSIUM 
FEEDBACK CONTROL SYSTEM IN SHEEP ACTIVELY IM-
MUNIZED WITH AN ALDOSTERONE-PROTEIN CONJUGATE 
INTRODUCTION 
It is well known that the plasma electrolyte level in man and 
in animals is dependent on the plasma concentration of aldosterone 
(August et al., 1958; Ross, 1963; Knöchel and White, 1973; Young 
et al., 1977).The mechanism by which aldosterone regulates the 
plasma electrolyte level is an active sodium reabsorption and 
potassium secretion across the tubular epithelial cells of the 
kidney. Therefore an increased plasma aldosterone level would 
result in an increased plasma sodium and a decreased plasma 
potassium concentration whereas a decreased aldosterone level has 
the opposite effect. On the other hand between aldosterone and 
potassium a regulatory feedback interrelationship exists whereby 
aldosterone increases the renal potassium excretion and plasma 
potassium stimulates the adrenal aldosterone production (Knöchel 
and White, 1973; Himathongkam et al., 1975; Corvol et al., 1977; 
Young et al., 1977) . 
In this study, plasma sodium and potassium concentrations in 
control sheep and in sheep actively immunized with aldosterone 
21-monohemisuccinate-BSA are presented. The electrolyte concentra-
tions are considered in view of the free aldosterone levels 
described in Chapter 3. This in order to investigate how free 
aldosterone and electrolyte levels are related and in what manner 
these relations are affected by active immunization against aldos-
terone . 
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MATERIALS AND METHODS 
Studies were carried out on eighteen Texel White ewes fed on 
a normal diet with unrestricted access to food and water. Nine 
animals were immunized with aldosterone 21-monohemisuccinate-BSA 
(Steraloids) according to the method described in Chapter 3. Nine 
sham-immunized sheep served as controls. 
Plasma sodium and potassium concentrations were measured with 
an Eppendorf flame photometer to a precision of + 0.8 (SD)% for 
sodium and + 1.8 (SD)% for potassium (SD based on ten replicate 
determinations on one sample). Free plasma aldosterone values 
presented in this study were previously described in Chapter 3. 
Results are quoted as mean values and the standard error of the 
mean (SEM). Student's t-test for non-paired comparisons was used 
in the statistical evaluation of the data obtained. Differences 
were considered to be significant when the P-value was less than 
0.05. Correlation tests were performed by linear regression ana­
lysis at a significance level of ρ < 0.05. 
RESULTS 
Plasma sodium and potassium 
Fig. 4.1 shows mean sodium and potassium concentrations in 
plasmas from immunized and control sheep before and during the 
experimental period. Mean plasma sodium levels of the individual 
animals before the experimental period (n=6) ranged from 145.8 
to 149.0 and from 145.2 to 150.3 mEq/l for immunized and control 
sheep, respectively. During the experimental period, from week 3 on, 
the mean plasma sodium concentrations (n=22) of the immunized sheep 
ranged from 138.3 to 142.2 and of the controls from 140.5 to 143.8 
mEq/l. Mean plasma sodium levels before immunization of immune and 
control sheep were not significantly different (p > 0.05). During 
the experimental period, however, the mean sodium concentrations 
of the immunized sheep were significantly lower (p < 0.005). Two 
weeks after primary immunization the mean plasma sodium concentra­
tion decreased in the immunized sheep as compared with the controls 
and remained thereafter below the control values throughout the 
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Fig. 4.1 Plasma concentration of free aldosterone, sodium and 
potassium in nine sheep immunized with aldosterone 21-monohemi-
succinate-BSA ( ) compared with that in nine control sheep 
( ) before and during the experimental period. Values 
represent means + SEM. Statistically significant differences 
are indicated by (*). 
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observed period. The plasma sodium concentration in the immune 
group was significantly lower at week 3 (p < 0.01),4 (p < 0.02), 
8 (p < 0.05), 26 (p < 0.02) and 37 (p < 0.02) after primary 
immunization when compared with values at the same times in the 
control group. Plasma sodium levels in the period before immuniza­
tion in the immune and control group were not significantly 
different. The mean plasma sodium concentrations of immune and con­
trol group were significantly correlated during the experimental 
period (r=0.96, ρ < 0.001, n=22) from week 3 on. 
Mean plasma potassium levels of the individual animals before 
the experimental period (n=6) ranged from 5.2 to 5.7 mEq/1 and from 
4.8 to 5.6 mEq/1 for immune and control group, respectively. During 
the experimental period, from week 3 on, the mean plasma potassium 
concentrations (n=22) of the immunized sheep ranged from 4.8 to 
5.2 mEq/1 and of the controls from 4.3 to 5.0 mEq/1. Mean potassium 
levels before immunization of immune and control group were not 
significantly different (p > 0.05). During the experimental period, 
however, the mean potassium concentrations of the immunized sheep 
were significantly higher (p < 0.001). The plasma potassium 
concentration significantly increased in the immunized sheep as 
compared with the controls, 3 weeks after primary immunization 
(p < 0.001). Mean values were 5.53 + 0.08 mEq/1 (+ SEM) and 4.96 
+0.06 mEq/1 for the immune and control group, respectively. Except 
for week 37, mean plasma potassium values of the immune group 
remained thereafter higher than the control values throughout the 
experimental period. The values were significantly higher at week 
4 (p < 0.02), 6 (p < 0.005), 8 (p < 0.02), 11 (p < 0.01), 14 
(p < 0.05), 16 (p < 0.0025, 32 (p < 0.005), 34 (p < 0.05), 43 
(p < 0.02), 45 (p < 0.02), 51 (p < 0.05), 53 (p < 0.05) and 55 
(p < 0.02) after primary immunization. Plasma potassium levels in 
the period before immunization in the immune and control group 
were nog significantly different. The mean plasma potassium concen­
trations of immunized and control animals were significantly 
correlated during the experimental period (r=0.93, ρ < 0.001, n=22) 
from week 3 on. 
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plasma potassium (mEq/l ) 
Fig. 4.2 Relat ionship between plasma potassium and free plasma 
aldosterone concentrat ion in nine sheep a c t i v e l y immunized with 
aldosterone 21-monohemisuccinate-BSA (·) (n=137) and in nine 
contro l sheep (o)(n=141). The regress ion l i n e represents the 
mean l i n e a r regress ion l i n e of the nine animals. 
Correlat ions between plasma e l e c t r o l y t e s and free plasma aldosterone 
Fig. 4.2 shows the r e l a t i o n s h i p between plasma potassium and 
free plasma aldosterone in immunized and contro l sheep during the 
experimental period from week 3 on. In both groups the c o r r e l a t i o n 
between plasma potassium and free aldosterone was s t a t i s t i c a l l y 
s i g n i f i c a n t . For the immune group the c o r r e l a t i o n c o e f f i c i e n t s of 
the indiv idual animals ranged from 0.37 (n=15) t o 0.69 (n=16) with 
a mean value of 0.53 + 0.04 (+SEM, ρ < 0 .001, n=9). For the contro l 
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group the correlation coefficients of the individual animals 
ranged from 0.07 (n=16) to 0.65 (n=15) with a mean value of 0.43 
+ 0.07 (+SEM, ρ < 0.005, n=9). The slope of the regression lines 
of immunized and control sheep was significantly different 
(p < 0.0025). The mean slope was 0.14 + 0.01 (+SEM, n=9) and 
0.08 + 0.01 (+SEM, n=9) for immune and control group, respectively. 
Neither in the immune, nor in the control group a significant 
correlation could be detected between plasma sodium and free plasma 
aldosterone. The mean value of the correlation coefficients of the 
individual animals was 0.06 + 0.05 (+SEM, ρ > 0.05, n=9) and 0.20 
+0.08 (+SEM, ρ > 0.05, n=9) for immunized and control sheep, 
respectively. 
DISCUSSION 
Plasma potassium has shown to be an important stimulatory 
factor of the aldosterone secretion by the adrenal glomerulosa 
cells. This represents an important part of the homeostatic system 
which protects the organism from dangerous hyperkaliemia since 
aldosterone on its turn induces kaliuresis. Hypokaliemia on the 
other hand, turns off aldosterone secretion and operates in that 
way to promote potassium conservation in the kidney. When neutra­
lization of biological active aldosterone, as a result of immuni­
zation, would lead to a hypomineralocorticoid state one might 
expect serious derangements in the potassium balance. Interestingly, 
in this Chapter is demonstrated that the plasma potassium concen­
trations in the immunized sheep were significantly correlated with 
those of the control animals during the experimental period. This 
finding indicates that in the immunized sheep the cybernetics of 
the hormonal control system are essentially operative. An inter­
pretation which is supported by the positive correlation found 
between plasma potassium and free aldosterone levels (Fig. 4.2). 
Obviously this correlation, which is present in the control animals 
as well, is not lost by immunization. 
It is emphasized that the aldosterone-potassium interrelation­
ship, which appears to be present in the control sheep, has been 
described in the literature almost exclusivelv under conditions 
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of potassium loading in man and in animals (Blair-West et al., 1962; 
Funder et al., 1969; Dluhy et al., 1972; Himathongkam et al., 1975; 
Corvol et al., 1977). Even small changes in plasma potassium concen-
tration, as a result of potassium infusion, have shown to stimulate 
the aldosterone secretion (Himathongkam et al., 1975). As far as we 
know there is only one publication reporting a significant positive 
correlation between plasma potassium and aldosterone levels without 
experimental potassium loading (Davies et al., 1979). 
Neither in the immune, nor in the control group a significant 
correlation could be detected between plasma sodium and free plasma 
aldosterone concentration. This agrees with the studies of Young 
et al (1976, 1977) on the aldosterone feedback system for controling 
plasma sodium and potassium concentration in dogs. It was concluded 
from these experiments that the aldosterone feedback system is not 
the prime contrôler of sodium concentration but that plasma 
sodium must be controlled by other feedback mechanisms beside the 
aldosterone system. Whereas the plasma potassium concentration 
appeared to be controlled mainly by the aldosterone feedback 
mechanism. 
In the present study it was found that an increase in plasma 
potassium is accompanied by an increase in free plasma aldosterone 
concentration in both control and immunized sheep (Fig. 4.2). 
Since sheep are ruminant herbivores there is a continuous and 
rather high dietary potassium intake in these animals. So the 
increase of free plasma aldosterone levels, following increased 
secretion, protects the sheep from hyperkaliemia. The relation 
between plasma potassium and free aldosterone, which may be viewed 
as a dose-response relationship, is different in control and 
immunized sheep. The rise in free plasma aldosterone following an 
increase in plasma potassium is sharper in controls than in 
immunized animals. Therefore it can be understood that a rise in 
plasma potassium leads to a stronger stimulation of potassium 
excretion and sodium retention by the kidney in controls than in 
immunized sheep. In its turn this must lead to higher average 
plasma potassium levels and lower sodium levels in the immunized 
animals (Fig. 4.1). Thus, the immunized sheep are in a state of 
relative hypoaldosteronism caused by a decreased response of free 
plasma aldosterone levels to potassium intake. 
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A side effect of the immunization procedure could be the 
development of immune complexes, which spontaneously precipitate in 
the renal glomeruli causing glomerulonephritis. Witting et al. (1979) 
demonstrated the occurrence of immune complex orecipitation in 58% 
and glomerulonephritis in 50% of the kidneys of rabbits actively 
immunized with a testosterone-3-BSA conjugate. Similar findings 
were reported by Kof1er et al. (1976) in the kidneys of rabbits 
passively immunized with luteinising hormone antiserum. In the 
present study it was not investigated whether active immunization 
with aldosterone 21-monohemisuccinate-BSA is followed by immune 
complex precipitation and glomerulonephritis in the kidneys of 
the experimental animals. It is possible that the occurrence 
renal damage may have an effect on the electrolyte metabolism 
in the kidneys resulting in a decreased plasma sodium and increased 
plasma potassium concentration. However, the patterns of plasma 
electrolyte levels of the immunized sheep were significantly 
correlated with those of the control animals during the experimental 
period indicating a common regulation mechanism. Whereas renal 
damage is supposed to exert a rather non-specific effect on the 
plasma electrolyte levels of the immunized sheep. The change in 
plasma electrolytes observed in the immunized animals occurred at 
2 and 3 weeks after primary immunization and remained relatively 
constant during the experimental period (Fig. 4.1). In the study 
of Witting et al. (1979) it was demonstrated that the degree of 
immune complexs precipitation depends on the duration of immunization 
with the most severe degrees at 10 and 16 weeks after primary immuni-
zation. Thus, it seems inlikely that renal damage is the cause of 
the change in plasma electrolyte levels found in the immunized 
sheep. 
A possible explanation for the decreased response of free 
plasma aldosterone to potassium intake in the aldosterone-immunized 
sheep can be found in the strongly modified relation between 
aldosterone secretion and free plasma concentration. An increase 
in plasma potassium stimulates the adrenal aldosterone secretion to 
obtain an elevation of the free plasma aldosterone concentration. 
However, the aldosterone secreted in the blood is almost completely 
bound by the circulating antibodies. In view of the tremendously 
increased total aldosterone levels it will take large amounts of 
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aldosterone and probably some time, before the increased aldosterone 
secretion is reflected in elevated free levels. In control sheep an 
increased aldosterone secretion is reflected immediately in an 
increased free plasma aldosterone concentration. Delayed appearance 
of free aldosterone results in increased potassium levels which in 
turn stimulates the aldosterone secretion. Finally, free plasma 
aldosterone will be elevated, but not strong enough to keep 
sodium and potassium levels within the same range as in the control 
animals. This would solve the apparent contradiction of an elevated 
free level and an increased aldosterone production rate as observed 
in Chapter 3. 
SUMMARY 
In a group of nine sheep the effect of active immunization 
against aldosterone on the plasma electrolyte levels and aldosterone-
potassium feedback system was studied. Plasma sodium and plasma 
potassium concentrations were decreased and increased, respectively, 
during the experimental period. The control system regulating 
plasma electrolyte concentrations, however, was considered to be 
still operative since mean plasma sodium and potassium concentra­
tions were significantly correlated with the corresponding concen­
trations of the control group (r=0.96, ρ < 0.001; r=93, ρ < 0.001, 
respectively). Also a significant positive correlation was found 
between plasma potassium and free plasma aldosterone concentration 
in both immunized and control sheep. Mean value of the correlation 
coefficients of the individual animals was 0.53 + 0.04 (+SEM, 
ρ < 0.001) and 0.43 + 0.07 (+SEM, ρ < 0.005) for immunized and 
control sheep, respectively. The slope of the regression lines of 
immunized and control sheep was significantly different (p < 0.0025). 
Mean slope was 0.14 + 0.01 (+SEM, n=9) and 0.08 + 0.01 (+SEM, n=9) 
for immune and control group, respectively. No significant correla­
tion was obtained between plasma sodium and free plasma aldosterone 
concentration. It is suggested that the sheep actively immunized 
against aldosterone are in a state of relative hypoaldosteronism 
caused by a decreased response of free plasma aldosterone to 
potassium intake. 
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APPENDIX 
In this Chapter it was shown that active immunization against 
aldosterone resulted in lowered plasma sodium and elevated plasma 
potassium levels while the free plasma aldosterone concentration 
was increased. It was suggested that the immunized animals were 
in a state of relative hypoaldosteronism caused by a decreased 
response of free plasma aldosterone to potassium intake. An expla-
nation was given in terms of a modified relation between the 
secretion and the free plasma concentration of aldosterone. The 
results of this work gave rise to the following short-term experi-
ments to investigate this relation in immunized and control sheep. 
In the first experiment, increased aldosterone secretion was 
simulated by intravenous infusion of aldosterone. In the second 
experiment, aldosterone secretion was stimulated by potassium 
chloride (KCl) infusion. The effect of both exogenous administered 
and endogenous produced aldosterone on total and free plasma 
aldosterone levels was determined. 
Materials en methods 
Experiments were carried out on fourteen Texel White ewes weighing 
68-84 kg, fed on a normal diet with unrestricted access to food and 
water. Seven animals were immunized with aldosterone 21-monohemi-
succinate-BSA (Steraloids) according to the method described in 
Chapter 3. At the time of the experiments the antibody titres 
ranged from 400 to 465,000. Seven sham-immunized sheep served as 
controls. Intravenous infusions were given through a polyethylene 
cannula inserted into the external jugular vein. Blood samples were 
taken from the jugular vein opposite to that receiving the infusion. 
Aldosterone (CIBA), stored as a concentrated solution in ethanol, 
was diluted in 5% glucose and infused at a rate of 40 ml/h using a 
constant infusion pump. The total amount of aldosterone given in 
1 h was 150 \ig. KCl was dissolved in 5% glucose and infused at a 
constant rate of 20 ml/h for 2 h. The total amount KCl infused was 
100 mEq for each animal. Blood samples were taken before and after 
the infusion for the determination of plasma potassium and total 
and free plasma aldosterone concentrations. 
Total plasma aldosterone levels were determined by radioimmuno-
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assay as described in Chapter 1. This method was used with some 
modifications for plasma taken from immunized animals. Prior to 
extraction the recovery tracer was incubated with 0.1 ml of plasma 
at 4 С for 18 h. Dissociation of the antibody-aldosterone complex 
was obtained by lowering the plasma pH using 20 ul 5N HCl. Free 
plasma aldosterone concentration was determined by a combined 
equilibrium dialysis and radioimmunoassay procedure as described 
in Chapter 2. Plasma potassium concentration was measured with an 
Eppendorf flame photometer. 
Results are quoted as mean values and the standard error of the 
mean (SEM). Willcoxon's rank sum test for paired and non-paired 
comparisons were used in the statistical evaluation of the data 
obtained at a significance level of ρ < 0.05. 
Results and discussion 
Fig. 4.3 shows the total and free plasma aldosterone concentra­
tion in seven control and seven immunized sheep, before and after 
infusion of aldosterone. Total plasma aldosterone concentration 
increased significantly from 7.5 + 1.3 ng/100 ml (+SEM) to 135 + 11 
ng/100 ml in control animals (p < 0.02) and from 7,936 + 2,415 ng/ 
100 ml (+SEM) to 10,989 + 2,787 ng/100 ml in immunized animals 
(p < 0.02). Free plasma aldosterone concentration in the control 
group increased significantly from 2.8 + 0.7 ng/100 ml (+SEM) to 
36.4 + 3.7 ng/100 ml (p < 0.02). In the immunized group no signifi­
cant changes in free plasma aldosterone concentration were observed. 
The values were 3.7 + 0.6 ng/100 ml (+SEM) before and 4.1 + 0.6 ng/ 
100 ml after infusion (p > 0.05). 
The plasma potassium and the total and free plasma aldosterone 
concentration in seven control and seven immunized sheep before 
and after KCl infusion is illustrated in Fig. 4.4. Plasma potassium 
concentration increased significantly from 4.4 + 0.2 mEq/1 (+SEM) 
to 5.6 + 0.3 mEq/1 in control animals (p < 0.02) and from 4.7 + 
0.3 mEq/1 (+SEM) to 6.5 + 0.6 mEq/1 in immunized animals (p < 0.02). 
The increase in plasma potassium concentration in immunized sheep 
was 1.8 + 0.6 mEq/1 (+SEM), which was not significantly different 
from the increase of 1.2 + 0.3 mEq/1 in the control sheep (p > 0.05). 
This increase in plasma potassium concentration resulted in elevated 
total plasma aldosterone levels in both control and immunized 
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total plasma aldosterone 
(ng/100ml) free plasma aldosterone -(ng/raOml) 
Fig. 4.3 Total and free plasma aldosterone concentration in seven 
control (о) and seven aldosterone-iramunized sheep (·) before and 
after the intravenous infusion of 150 lig aldosterone over a lb period. 
a n i m a l s . In t h e c o n t r o l group t h e t o t a l plasma a l d o s t e r o n e concen­
t r a t i o n be fore i n f u s i o n was 4.5 + 0.9 ng/100 ml (+SEM), a f t e r 
i n f u s i o n the c o n c e n t r a t i o n went up t o 10.9 + 2.2 ng/100 ml. In t h e 
immunized group the corresponding v a l u e s were 7,922 + 2,312 ng/ 
100 ml (+SEM) before and 8,899 + 2,243 ng/100 ml a f t e r i n f u s i o n . 
Free plasma a l d o s t e r o n e c o n c e n t r a t i o n i n t h e c o n t r o l group i n ­
c r e a s e d s i g n i f i c a n t l y from 1.8 + 0.4 ng/100 ml (+SEM) t o 4.7 + 0.9 
ng/100 ml (p < 0 . 0 2 ) . In t h e immunized group t h e f r e e plasma a ldos­
t e r o n e c o n c e n t r a t i o n was 4.9 + 0.3 ng/100 ml (+SEM) before and 
5.2 + 1.0 ng/100 ml a f t e r i n f u s i o n (p > 0 . 0 5 ) , which i s a 
n o n - s i g n i f i c a n t change. 
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píasma potassium -
(mEq/l) 
total plasma aldosterone 
(ng/100 mi) free plasma aldosterone—| (ng/100 m ) 
control 
aften 
Fig. 4.4 plasma potassium and total and free plasma aldosterone 
concentration in seven control (o) and seven aldosterone-immunized 
sheep (·) before and after the intravenous infusion of 100 mEq KCl 
over a 2h period. 
Potassium loading is a well known stimulus of aldosterone secre-
tion in man and experimental animals (Blair-West et al., 1962; Funder 
et al., 1969; Dluhy et al., 1972; Himathongkam et al., 1975; Corvol 
et al., 1977). The present experiments demonstrate also an aldosterone 
stimulating effect of potassium in immunized and control sheep. In all 
control animals total and free plasma concentrations increased as res-
ponse to a rise in plasma potassium levels. In each immunized sheep 
total plasma aldosterone levels became elevated after KCl infusion. 
This indicates that in the aldosterone-immunized sheep, in spite of an 
already increased production, the adrenal aldosterone secretion still 
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can be further stimulated. However, this increase in aldosterone 
secretion resulted, over the time course utilised in the experiment, 
not in measurable changes of free plasma concentrations. Similar 
observations were made in the aldosterone infusion experiment. There 
was a considerable increase in total plasma aldosterone concentration 
whereas the free plasma concentration remained unchanged. According 
to an increase in total plasma aldosterone of almost 40% in the 
immune group one would expect the same increase in the free plasma 
concentration. Since the free level is a result of an equilibrium 
between the protein-bound and free aldosterone as demonstrated in 
the controls. In the case of the KCl infusion experiment the un-
changed free plasma aldosterone levels, in the presence of an 
increase of total plasma aldosterone of about 12%, could be 
ascribed to the limited precision of the assay procedure. This does 
not account, however, for the free levels in the aldosterone 
infusion experiment. In regard of this it seems unlikely that the 
free plasma aldosterone concentration in the immunized sheep could 
change in response to various stimuli. A conclusion which is not 
supported by the finding that the free plasma aldosterone concen-
tration was significantly correlated to the plasma potassium levels 
as demonstrated in this Chapter. Also it is shown in Chapter 3 that 
on long-term a significant correlation exists between free and total 
plasma aldosterone concentration which is present when the amount 
of antibody-binding sites do not change appreciably. An explanation 
for the unresponsiveness of the free plasma aldosterone concentration 
in the aldosterone infusion experiment is so far not available. One 
can speculate that the aldosterone infusion may induce a rapid 
formation of antibodies which bind at the same time the administered 
aldosterone. 
Together the data of the aldosterone and KCl infusion experiments 
indicate that an increased aldosterone secretion in aldosterone-
immunized sheep is, on short-term, not reflected in increased free 
plasma aldosterone levels. Probably only after a long-term stimulation 
the free plasma aldosterone concentration is to be elevated by an 
increased secretion. This would confirm the suggestion that the 
changed plasma electrolyte levels observed in aldosterone-immunized 
sheep are a result of a delayed appearance of free plasma aldosterone 
in response to potassium stimulation. 
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SUMMARY AND CONCLUSIONS 
In this thesis, effects of active immunization of sheep against 
aldosterone have been studied in order to investigate whether - or 
to what extent - immunization against this steroid hormone leads 
to neutralization of hormonal activity. Plasma levels of sodium and 
potassium were measured as an indicator of aldosterone hormonal ac-
tivity. The effect of immunization on circulating aldosterone was 
determined by measurements of total and free plasma aldosterone, 
antibody titres and aldosterone metabolic clearance, to obtain in-
sight into the mechanism by which neutralization takes place. 
In Chapter 1 the development and evaluation of a radioimmuno-
assay for the measurement of total aldosterone in plasma is des-
cribed. The basis for this assay was provided by a specific anti-
serum raised in sheep against aldosterone 21-monohemisuccinate-bo-
vine serum albumin (BSA) and the use of dextran-coated charcoal to 
separate antibody-bound and free aldosterone. In combination with 
an extraction of plasma aldosterone by means of dichloromethane 
and a purification achieved by paper chromatography, this radio-
immunoassay had sufficient precision and specificity to suit the 
purpose. 
Chapter 2 describes the development of an equilibrium dialy-
sis method for the determination of the free, non protein-bound con-
centration of plasma aldosterone. In this method, free aldosterone 
is measured directly in plasma equilibrium dialysates by radioimmuno-
assay. In contrast to conventional methods, which employ radiolabelled 
hormone to determine the free hormone fraction, this method does 
not rely on extreme tracer purity, and therefore it is suited for 
the measurement of free plasma aldosterone levels in the presence 
of extremely large quantities of bound hormone. The direct radio-
immunoassay is a modification of an assay developed for the direct 
assay of total aldosterone in human plasma. Both extraction and 
purification can be eliminated in this assay by using a highly 
specific antiserum, obtained by immunizing sheep with aldosterone 
-(18, 21)- diacetate-3-carboxymethyloxime-BSA, together with 
8-anilino-l- naohtalene-sulfonic-acid (ANS) as an agent to inhibit 
binding of aldosterone to plasma proteins. 
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Using the methods described in Chapter 1 and 2, total and free 
aldosterone levels were measured in nine sheep actively immunized 
against aldosterone 21-monohemisuccinate-BSA (Chapter 3). The ani-
mals were studied for a period exceeding one year together with 
nine sham-immunized sheep as controls. Measurements were carried 
out in plasmas taken at regular intervals before, during and after 
a period of booster injections. All immunized animals produced anti-
bodies. Antibody formation was accompanied by a tremendous increase 
of total plasma aldosterone levels, which were correlated with the 
antibody titres. Such an increase was not observed with the free 
plasma aldosterone levels. Still these were moderately, though 
significantly elevated over those in control animals. 
By determining the plasma disappearance of an injected dose 
of radiolabelled aldosterone at a moment when total plasma aldo-
sterone levels had reached a plateau it was found that in the 
immunized animals the metabolic clearance rate (MCR) was markedly 
decreased. This confirmed the assumption that binding to antibodies 
strongly reduces the availability of the hormone for degradation. 
However, the absolute disposal rate, calculated as the product of 
MCR and total plasma aldosterone concentration was still elevated. 
This led to the conclusion that the elevated total aldosterone 
levels must be attributed not exclusively to a decrease of hormone 
disposal but also to a strongly increased secretion rate. 
Total and free aldosterone levels in control sheep moved es-
sentially parallel, according to what might be expected from the 
constant concentration of the aldosterone-binding plasma proteins. 
In the immunized sheep, a similar relation between total and free 
aldosterone was found when antibody levels had reached a plateau. 
The patterns of free plasma aldosterone in control and immune group, 
though at a different level, were significantly correlated during 
the experimental period indicating that free plasma aldosterone 
in the immunized sheep was still under the influence of the same 
factors regulating free aldosterone in control sheep. 
In Chapter 4 the plasma levels of potassium and sodium and 
their relation to free plasma aldosterone in control and aldoste-
rone- immun i zed sheep are described. It was found that the plasma 
potassium levels in immunized sheep were significantly elevated 
over those in controls. Plasma sodium was significantly decreased. 
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Fluctuations of plasma electrolyte levels in controls were 
parallelled by a similar pattern in immunized sheep. Between sodium 
and potassium no correlation was found. Plasma potassium - but not 
sodium - levels were positively correlated with free aldosterone 
both in control and immunized sheep, indicating that plasma potas-
sium is a primary factor in the control of free aldosterone levels. 
A significant difference between the free aldosterone/potassium 
relation in control and immunized sheep was demonstrated, in that 
free aldosterone rise with potassium in controls is stronger than 
in the immunized group. Assuming that potassium excretion and so-
dium retention are dependent of free aldosterone, the lowered res-
ponse of free aldosterone to potassium intake was held responsible 
for the moderate degree of hyperkaliemia and hyponatriemia found. 
In seperate experiments it was found that either aldosterone 
or potassium infusion led to a much stronger (relative) rise of 
total and free aldosterone in controls than in immunized sheep. 
Most probably this is the consequence of the large circulating 
aldosterone pool. These findings suggested that also increases of 
aldosterone secretion by the adrenals in response to potassium in-
take are less effective in achieving a rise in free aldosterone. 
The first objective of this study was to find out whether acti-
ve immunization against aldosterone leads to neutralization of hormo-
nal activity. When considering the regulation of plasma sodium and 
potassium levels as the most important hormonal activity of aldo-
sterone, the finding of lowered plasma sodium and elevated plasma 
potassium levels as described in Chapter 4 show that the answer to 
this question must be affirmative. As to the extent to which neutra-
lization takes place, it must be stressed that the effects ob-
served in this study are far remote from those resulting from adre-
nalectomy with mere glucocorticoid suppletion. The experimental 
animals appeared to be in good health and no progression of hypona-
triemia or hyperkaliemia occurred indicating sodium loss and po-
tassium accumulation. Furthermore, the plasma electrolyte levels 
showed the same pattern as in control animals, which thought to 
originate from the interplay of electrolyte intake and regulatory 
factors of which aldosterone is one of the most prominent. Thus, 
neutralization of aldosterone hormonal activity remains confined 
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to the achievement of a mild hypoaldosteronism. 
Also, insight was obtained how the modified plasma electrolyte 
levels are brought about. The crucial point is thought to be the 
modified relation between plasma potassium and free plasma aldo-
sterone (Chapter 4), which is the cause of an insufficient rise of 
free plasma aldosterone in response to potassium intake, so that 
plasma potassium and sodium levels are not normalized in spite of 
elevated free plasma aldosterone levels. Thus, the paradoxial situa-
tion arises in which elevated free plasma aldosterone levels go 
together with a state of moderate hypoaldosteronism. As this rise 
of the free plasma aldosterone level does not result in an ade-
quate reduction of the plasma potassium levels to normal values, 
the set point in the homeostatic control system clearly is turned 
to a higher level for plasma potassium and free aldosterone. One 
might speculate about the underlying cause for this phenomenom. As 
there are no indications of a reduced sensitivity of the adrenals 
of the immunized animals to potassium stimulation, the phenomenom 
most probably can be ascribed to a reduction in the effectiveness 
of aldosterone secretion to promote a rise in the plasma level of 
free aldosterone. Either or both of two mechanisms might be responsi-
ble. First, the higher aldosterone disposal rate found in the immu-
nized sheep (Chapter 3) could be responsible for this reduction. 
Secondly, in the presence of the large amount of antibodies, an 
increased secretion of aldosterone contributes almost exclusively 
to the bound fraction of circulating aldosterone. 
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SAMENVATTING EN CONCLUSIES 
In dit proefschrift zijn een aantal effecten beschreven die 
optreden bij actieve immunisatie van schapen tegen aldosteron. 
Het onderzoek diende om na te gaan in hoeverre imrmnisatie tegen dit 
steroidhormoon neutralisatie van de hormonale activiteit tot gevolg 
heeft. Als maat voor de hormonale activiteit van het aldosteron 
werden de natrium- en kaliumspiegels in plasma bepaald. Het effect 
van immunisatie op het aldosteron werd bepaald door meting van het 
totale en vrije aldosteron in plasma, de antilichaam titers en de 
metabole klaring van het aldosteron. Deze parameters dienden om in-
zicht te krijgen in het mechanisme waardoor neutralisatie plaats-
vindt. 
In hoofdstuk 1 wordt de radioimmunoassay van totaal aldosteron 
in plasma beschreven en geëvalueerd. Uitgangspunt bij deze bepaling 
was een specifiek antiserum, dat was opgewekt in schapen tegen 
aldosteron 21- monohemisuccinate-BSA en het gebruik van charcoal-
dextran om het vrije en het aan antilichaam gebonden aldosteron te 
scheiden. Toepassing van een extractie van aldosteron uit plasma 
door middel van dichloormethaan, samen met een papierchromatogra-
fische zuivering resulteerde in een radioimmunoassay die voldoende 
nauwkeurig en specifiek was voor het beoogde doel. 
In hoofdstuk 2 is een methode voor evenwichtsdialyse beschreven, 
die werd gebruikt voor het bepalen van de vrije, niet aan eiwit 
gebonden, aldosteronconcentratie m plasma. In deze methode wordt 
de concentratie van het vrije aldosteron in dialysaten van plasma 
direct gemeten met behulp van een radioimmunoassay. In tegenstelling 
tot de gebruikelijke methoden, waarbij gebruik wordt gemaakt van 
radioactief gemerkt hormoon om de vrije fractie te bepalen, is deze 
methode niet afhankelijk van de zuiverheid van het radioactief 
gemerkte hormoon en derhalve geschikt voor het meten van de vrije 
aldosteronspiegels in plasma in aanwezigheid van een grote hoeveel-
heid gebonden hormoon. De toegepaste radioimmunoassay is een 
modificatie van een bepaling, die was ontwikkeld voor het recht-
streeks meten van totaal aldosteron m humaan plasma. Zowel 
extractie als zuivering van plasma aldosteron kunnen in deze 
bepaling worden omzeild door gebruik te maken van een zeer specifiek 
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antiserum, verkregen door schapen te inununiseren met aldosteron-
(18, 21)- diacetate-3-carboxymethyloxime-BSA, in combinatie met 
8-anilino-l-naphtalene-sulfonic-acid (ANS) om de binding van aldos-
teron aan plasma eiwitten tegen te gaan. 
Met behulp van de in hoofdstuk 1 en 2 beschreven methoden, 
werden de totale en vrije aldosteronspiegels in plasma gemeten van 
negen schapen die actief geïmmuniseerd waren met aldosteron 21-
monohemisuccinate - BSA (hoofdstuk 3). Met deze dieren werd gedurende 
ruim een jaar geëxperimenteerd, samen met negen schijn-geiiranuniseerde 
schapen als controle's. Met regelmatige tussenposen werden ббг, 
tijdens en na een periode van booster injecties plasma's verkregen, 
waarin de metingen werden uitgevoerd. Alle geiiranuniseerde dieren pro­
duceerden antilichamen. Deze vorming van antilichamen ging gepaard 
met een enorme stijging van de totale aldosteronspiegels, die gecor­
releerd waren met de titers van de antilichamen. De vrije aldosteron­
spiegels daarentegen waren slechts in geringe mate verhoogd ten op­
zichte van de controlewaarden, hoewel het verschil statistisch signi­
ficant was. Door het bepalen van de verdwijningssnelheid van een ge-
injecteerde dosis radioactief gemerkt aldosteron in plasma werd 
gevonden, dat de metabole klaringssnelheid (MCR) in de geïmmuniseerde 
dieren opvallend was afgenomen. Deze bepaling werd uitgevoerd op een 
tijdstip dat de totale aldosteronspiegels in plasma een plateau 
hadden bereikt. Dit bevestigt de veronderstelling dat door binding 
aan antilichamen de beschikbaarheid van het hormoon voor afbraak 
sterk wordt verlaagd. De absolute klaringssnelheid, berekend als het 
produkt van de MCR en de totale plasma aldosteronconcentratie, was 
echter toch verhoogd. Hieruit kan worden geconcludeerd dat de ver-
hoogde totale plasma aldosteronspiegels niet enkel moeten worden 
toegeschreven aan een verlaging van de hormoon uitscheiding, maar ook 
aan een sterk verhoogde secretiesnelheid. 
De totale en vrije aldosteronspiegels in controle schapen bleken 
parallel te lopen, hetgeen in overeenstemming is met de verwachting, 
aangezien aldosteron-bindende plasma eiwitten in een constante 
concentratie voorkomen. In de geïmmuniseerde schapen werd een soort-
gelijke relatie tussen het totale en het vrije aldosteron gevonden 
vanaf het tijdstip dat de titers van de antilichamen een plateau 
hadden bereikt. De patronen van het vrije plasma aldosteron in de 
controle dieren en in de geimmuniseerde dieren waren, ofschoon op 
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een verschillend niveau, significant gecorreleerd gedurende de 
experimentele periode. Blijkbaar werken de factoren die in controle 
dieren het vrije aldosteron in plasma reguleren op vrijwel ongestoorde 
wijze verder tijdens immunisatie, ondanks de aanwezigheid van een 
zeer hoge concentratie gebonden aldosteron. 
In hoofdstuk 4 zijn de natrium- en kaliumspiegels in plasma van 
geïmmuniseerde en controle schapen beschreven, evenals hun relatie 
tot het vrije plasma aldosteron. Er werd gevonden dat de plasma 
kaliumspiegels van geïmmuniseerde schapen significant verhoogd waren 
ten opzichte van die in de controle schapen. De natriumconcentratie 
in plasma was significant lager. Fluctuaties in plasma elektrolyten-
spiegels vertoonden in controle en geïmmuniseerde schapen eenzelfde 
patroon. Er bleek bij de controle dieren een positieve correlatie te 
bestaan tussen de kaliumspiegels en de vrije aldosteronspiegels in 
het plasma. Deze bevinding bevestigt de stelling in de literatuur, 
dat kalium een primaire aldosteron-stimulerende factor is. Tot nu 
toe was deze stelling gebaseerd op gegevens uit experimenten waarin 
kalium - in vivo of in vitro - werd toegediend. Bij de geïmmuniseerde 
schapen werd eveneens een positieve correlatie gevonden tussen kalium 
en vrij aldosteron. Dit regelmechanisme blijft blijkbaar intact 
tijdens de immunisatie. Toch werd een significant verschil aangetoond 
tussen de relatie vrij aldosteron versus kalium in controle en geïm-
muniseerde schapen. Het vrije aldosteron steeg onder invloed van het 
kalium in de controle's sterker dan in de geïmmuniseerde dieren. 
Ervan uitgaande, dat de kaliumexcretie en de natriumretentie afhan-
kelijk zijn van het vrije aldosteron, werd de verminderde reactie 
van vrij aldosteron op de stimulering door kalium gezien als de 
oorzaak van de matige hyperkalemie en hyponatremie. 
In afzonderlijke experimenten werd waargenomen, dat zowel een 
infuus met aldosteron als met kalium in de controle schapen een 
(relatief) veel sterkere stijging van totaal en vrij aldosteron tot 
gevolg had dan in de geïmmuniseerde dieren. Dit is zeer waarschijn-
lijk het gevolg van de grote aldosteron pool in deze dieren. Deze 
resultaten doen vermoeden dat ook een toename van de aldosteron 
secretie door de bijnier, als gevolg van kalium stimulering, minder 
effectief is om een stijging van het vrije aldosteron te bewerk-
stelligen. 
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Het doel van deze studie was op de eerste plaats om te onder-
zoeken of actieve immunisatie tegen aldosteron neutralisatie van 
de hormonale activiteit tot gevolg heeft. In aanmerking genomen, 
dat de regulatie van de plasma natrium- en kaliumspiegels de be-
langrijkste hormonale activiteit van het aldosteron is, leiden de 
resultaten van een verlaagd plasma natrium en een verhoogd plasma 
kalium (hoofdstuk 4) tot een bevestigend antwoord op deze vraag. 
Wat betreft de mate waarin neutralisatie plaatsvindt, moet worden 
benadrukt, dat de in deze studie waargenomen effecten ver afwijken 
van effecten die het resultaat zijn van bijmerextirpatie met 
suppletie van alleen glucocorticoiden. De proefdieren bleken in 
goede gezondheid te verkeren en er was geen toename van hyponatremie 
of hyperkalemie hetgeen zou kunnen wijzen op natrium verlies en 
kalium ophoping. Bovendien vertoonden de plasma electrolytenspiegels 
van de geïmmuniseerde dieren over de studieperiode hetzelfde patroon 
als die van de controle dieren. Een patroon dat waarschijnlijk ont-
staan is door de wisselwerking van elektrolyt opname en regulerende 
factoren, waarvan aldosteron een van de belangrijkste is. De neutra-
lisatie van de hormonale activiteit van het aldosteron blijft blijk-
baar beperkt tot een zwak hypoaldosteronisme. 
Eveneens werd nadere informatie verkregen over de wijze waarop 
deze veranderde plasma elektrolytenspiegels tot stand kwamen. Als een 
belangrijke oorzaak wordt gezien de veranderde relatie tussen het 
plasma kalium en het vrije plasma aldosteron (hoofdstuk 4). Er treedt 
een onvoldoende stijging op van het vrije plasma aldosteron, als ge-
volg van kalium stimulering, waardoor de plasma kalium en plasma 
natriumspiegels niet genormaliseerd worden ondanks verhoogde vrije 
plasma aldosteronspiegels. Zo ontstaat de paradoxale situatie, 
waarin verhoogde vrije plasma aldosteronspiegels samengaan met een 
toestand van gematigd hypoaldosteronisme. Blijkbaar is het "set 
point" in het homeostatische systeem op een hoger niveau ingesteld 
bij de geïmmuniseerde dieren. Aangezien er geen aanwijzingen zijn, 
dat een verlaagde gevoeligheid van de bijnier voor kalium stimulering 
hierbij een rol speelt, zou dit fenomeen kunnen worden toegeschreven 
aan ëën of beide van de volgende factoren: 1. de hogere snelheid 
waarmee aldosteron beschikbaar is voor afbraak en uitscheiding 
(hoofdstuk 3) 2. de zeer grote hoeveelheden bindende antilichamen 
die ertoe leiden dat gesecerneerd aldosteron bijna uitsluitend in de 
gebonden fractie terechtkomt. Deze laatste bespiegelingen gaan echter 
tot nu toe uit boven het feitelijk bewijsbare. 
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van verlaagde mineralocorticoide activiteit. 
dit proefschrift 
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De relatief sterk verhoogde productiesnelheid van aldosteron in 
schapen, actief geïmmuniseerd tegen aldosteron, wijst erop dat naast 
het vrije eveneens een deel van het aan anti lichaam gebonden aldos-
teron gemetaboliseerd wordt. 
dit proefschrift 
3 
De sterk verhoogde totale concentratie van aldosteron in het plasma 
van schapen die actief geiiranuniseerd zijn tegen aldosteron wordt 
hoofdzakelijk veroorzaakt door endogeen geproduceerd aldosteron. 
dit proefschrift 
4 
De positieve correlatie tussen de kaliumspiegels en de vrije aldos-
teronspiegels in plasma van schapen bevestigt het in de literatuur 
uitgesproken vermoeden, gebaseerd op waarnemingen tijdens kalium-
belasting en depletie, dat ook onder fysiologische omstandigheden 
kalium een primaire aldosteron-stimulerende factor is. 
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hun s p e c u l a t i e d a t de a l d o s t e r o n c o n c e n t r a t i e i n s p e e k s e l een maat 
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Het b e p a l e n van h e t v e r s c h i l t u s s e n de e l e c t r o n e g a t i e v e l a d i n g e n van 
h e t o r a l e en r e c t a l e s l i j m v l i e s vormt een goede maat voor m i n e r a l o -
c o r t i c o i d e a c t i v i t e i t . 
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9 
Gezien de voortschrijdende vervanging van zorgvuldig geplante bomen 
door zorgvuldig geplande gebouwen, kan Heyendaal niet langer beschouwd 
worden a l s een "landhuis" in de ware zin van het woord. 
Pey, I . (1982) Het landhuis Heyendaal t e Nijmegen, s t i j l en 
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Het voorstel om een snelheidsbeperking voor toerfietsers in te voeren, 
kan gezien worden als ingegeven door bezorgdheid voor het welzijn van 
de huidige ministerpresident. 
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